Patent Grant
11596588
The present disclosure generally relates to compositions for use in bleaching and/or coloring the hair.
The process of changing the color of hair, can involve depositing an artificial color onto the hair which provides a different shade or color to the hair, and/or lifting the color of the hair, such as lightening the color of dark hair to lighter shades.
In general, hair lightening or color lifting compositions and hair dyeing compositions possess an alkalinity such that these compositions have a pH value of above 7, typically being at pH 9 and above, and may generally require the presence of an alkalizing agent such as ammonia or an ammonia gas-generating compound and/or an amine or ammonium-based compound in amounts sufficient to make such compositions alkaline. This alkalizing agent causes the hair shaft to swell, thus allowing active agents into the hair.
Imparting a color change or color effect on hair can be done using permanent and semi-permanent or temporary hair coloring products. Conventional permanent hair coloring products are dye compositions comprising oxidation dye precursors, which are also known as primary intermediates or couplers. These oxidation dye precursors are colorless or weakly colored compounds which, when combined with oxidizing products, give rise to colored complexes by a process of oxidative condensation. The oxidizing products conventionally use peroxides such as hydrogen peroxide as oxidizing agents. Such permanent hair color products also contain ammonia or other alkalizing agents such as monoethanolamine (MEA) which causes the hair shaft to swell, thus allowing the small oxidative dye molecules to penetrate the cuticle and cortex before the oxidation condensation process is completed. The resulting larger-sized colored complexes from the oxidative reaction are then trapped inside the hair fiber, thereby permanently altering the color of the hair.
Semi-permanent dyeing uses direct dyes, which are nonionic or ionic dyes and colored compounds capable of producing a more or less pronounced change of the natural color of the hair, resistant to shampoo-washing several times. These dyes may or may not be used in the presence of an oxidizing agent. In contrast with oxidation dye precursors, a direct dye is a relatively voluminous molecule that does not penetrate easily into the core of the fiber.
The process of lifting the color of hair, generally also requires the use of compositions that comprise at least one oxidizing agent (e.g., hydrogen peroxide). Such oxidizing agents enter the hair shaft and react with melanin in the hair, thereby lightening the color of the hair. Additional agents, such as persulfate salts, may be added to accelerate the process.
While such hair compositions can effectively alter the color of hair, these chemical treatments can severely damage the hair fibers. Thus, in order to reduce or avoid the drawbacks mentioned above, as well as to improve the cosmetic performance of the treatment compositions, the use of new and additional ingredients and novel combinations of ingredients are continuously sought which can help prevent, ameliorate or reverse damage.
Nevertheless, the choice of ingredients or combinations of ingredients could pose difficulties insofar as they cannot be detrimental to other cosmetic attributes such as ease and uniformity of application, rheology or viscosity properties and stability of the compositions, color deposit and target shade formation, and/or result into more disadvantages such as increased damage or a less healthy look to the hair. It would therefore be desirable to provide the consumer with compositions and methods that can effectively treat the hair, e.g. lift the color of hair and/or deposit color onto hair in an efficient manner, while providing other cosmetic advantages such as shine, conditioning, fiber strength, and/or a healthy appearance to the hair, but avoiding or minimizing damage to the hair.
One aspect of the invention pertains to a hair color-altering composition. In one or more embodiments, the composition comprises:
In some embodiments, the at least one amino acid or amino sulfonic acid and/or salt thereof is taurine and/or a salt thereof. In one or more embodiments, the composition comprises from about 0.01 wt. % to about 10 wt. % of the at least one amino acid or amino sulfonic acid and/or a salt thereof. In some embodiments, the at least one amino acid or amino sulfonic acid and/or a salt thereof is present in an amount of from about 0.01 wt. % to about 5 wt. %. In one or more embodiments, the composition comprises at least 0.01 wt. % to about 10 wt. % of the at least one carboxylic acid and/or a salt thereof. In some embodiments, the at least one carboxylic acid and/or a salt thereof is present in an amount of from about 0.01 wt. % to about 7 wt. %. In one or more embodiments, the at least one carboxylic acid and/or a salt thereof is a tricarboxylic acid and/or a salt thereof. In some embodiments, the tricarboxylic acid and/or salt thereof is selected from the group consisting of citric acid, isocitric acid, aconitic acid, propane-1,2,3-tricarboxylic acid, trimesic acid, a salt thereof, and a mixture thereof. In one or more embodiments, the tricarboxylic acid and/or salt thereof is citric acid, and/or a salt thereof. In some embodiments, the composition further comprises one or more alkalizing agents. In one or more embodiments, the one or more alkalizing agents is selected from alkali metal carbonates, alkali metal phosphates, organic amines, hydroxide base compounds, and combinations thereof. In some embodiments, the one or more alkalizing agents is selected from the group consisting of ammonium hydroxide, monoethanolamine and combinations thereof. In one or more embodiments, the composition further comprises one or more fatty compounds selected from the group consisting oils, mineral oil, alkanes, fatty alcohols, fatty acids, fatty alcohol derivatives, alkoxylated fatty acids, polyethylene glycol esters of fatty acids, propylene glycol esters of fatty acids, butylene glycol esters of fatty acids, esters of neopentyl glycol and fatty acids, polyglycerol/glycerol esters of fatty acids, glycol diesters or diesters of ethylene glycol and fatty acids, esters of fatty acids and fatty alcohols, esters of short chain alcohols and fatty acids, esters of fatty alcohols, hydroxy-substituted fatty acids, waxes, triglyceride compounds, lanolin, ceramide, and mixtures thereof. In some embodiments, the composition further comprises one or more cationic polymers. In one or more embodiments, the one or more cationic polymers are selected from the group consisting of poly(methacryloyloxyethyl trimethylammonium chloride), polyquaternium-37, quaternized cellulose derivatives, polyquaternium-4, polyquaternium-6, polyquaternium-10, cationic alkyl polyglycosides, cationized honey, cationic guar derivatives, polymeric dimethyl diallyl ammonium salts and copolymers thereof with esters and amides of acrylic acid and methacrylic acid, copolymers of vinyl pyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, vinyl pyrrolidone-vinyl imidazolium methochloride copolymers, quaternized polyvinyl alcohol, polyquaternium-2, polyquaternium-7, polyquaternium-17, polyquaternium-18, polyquaternium-24, polyquaternium-27, and a mixture thereof. In some embodiments, the hair color-altering agent comprises and oxidative dye.
Another aspect of the invention pertains to a hair cosmetic composition for lifting or altering the color of keratinous substrates. In one or more embodiments, the composition comprises:
In some embodiments, the composition further comprises at least one amino acid or amino sulfonic acid, and/or a salt thereof selected from the group consisting of taurine, aspartic acid, cysteine, lysine, methionine, tyrosine, phenylalanine, carnitine, aminomethane sulfonic acid, aminopropane sulfonic acid, aminobutane sulfonic acid, aminohexane sulfonic acid, aminoisopropyl sulfonic acid, aminododecyl sulfonic acid, aminobenzene sulfonic acid, aminotoulene sulfonic acid, sulfanilic acid, chlorosulfanilic acid, diamino benzene sulfonic acid, amino phenol sulfonic acid, amino propyl benzene sulfonic acid, amino hexyl benzene sulfonic acid. In one or more embodiments, the at least one amino acid or amino sulfonic acid comprises taurine. In one or more embodiments, the composition further comprises at least one hair color-altering agent. In some embodiments, the at least one hair color-altering agent comprises at least one oxidative dye. In one or more embodiments, the at least one carboxylic acid and/or a salt thereof is present in an amount of about 0.05 wt. % to about 10 wt. % by total weight of the composition. In one or more embodiments, the at least one alkalizing agent is selected from the group consisting of monoethanolamine, ammonium hydroxide, and mixtures thereof. In some embodiments, the cationic polymer is selected from the group consisting of poly(methacryloyloxyethyl trimethylammonium chloride), polyquaternium-37, quaternized cellulose derivatives, polyquaternium-4, polyquaternium-6, polyquaternium-10, cationic alkyl polyglycosides, cationized honey, cationic guar derivatives, polymeric dimethyl diallyl ammonium salts and copolymers thereof with esters and amides of acrylic acid and methacrylic acid, copolymers of vinyl pyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, vinyl pyrrolidone-vinyl imidazolium methochloride copolymers, quaternized polyvinyl alcohol, polyquaternium-2, polyquaternium-7, polyquaternium-17, polyquaternium-18, polyquaternium-24, polyquaternium-27, and a mixture thereof. In one or more embodiments, the at least two fatty substances are selected from mineral oil, cetearyl alcohol, oleyl alcohol, glycol distearate, hydrogenated vegetable oil, and mixtures thereof. In some embodiments, the hair color-altering composition does not comprise a thickener, cellulose or gum. In one or more embodiments, the at least one surfactant comprises an anionic surfactant selected from oleic acid and/or a nonionic surfactant selected from deceth-3, oleth-30 and combinations thereof.
It should be understood that the various aspects are not limited to the arrangements and instrumentality shown in the drawings.
One aspect of the invention relates to hair color-altering compositions. The hair color-altering compositions at least comprise a hair color-altering agent and a carboxylic acid. In one or more embodiments, hair color-altering composition comprises
In some embodiments, the hair color-altering composition comprises
The presence of citric acid has surprisingly been found to positively affect the rheology characteristics of certain hair color-altering compositions, particularly in combination with several other ingredients (e.g., certain surfactants an fatty substances). Additionally, citric acid/or taurine may also provide protect the hair from damage when undergoing color alteration.
The hair color-altering compositions of the instant disclosure can be in a variety of forms. For example, in many instances, the hair color-altering compositions are in the form of a liquid, gel, lotion, crème, and/or spray. The hair color-altering compositions may be packaged in a variety of different containers, such as, for example, a ready-to-use container. Non-limiting examples of useful packaging include tubes, jars, caps, unit dose packages, and bottles, including squeezable tubes and bottles.
Amino Acid/Amino Sulfonic Acid
In some embodiments, the hair color-altering compositions comprise an amino acid or amino sulfonic acid. Amino acids are simple organic compounds containing both a carboxylic acid group (—COOH) and an amino group (—NH2). Amino sulfonic acids are simple organic compounds containing both a sulfonic acid group (—SO2OH) and an amino group (—NH2). Accordingly; the amino acids and amino sulfonic acids may be selected from compounds of Formula (I) and compounds of Formula (II):
wherein R represents a hydrogen atom, a linear or branched, preferably linear, C1-C5 alkyl group, said alkyl group being optionally substituted with at least one group chosen from hydroxyl, —C(O)—OH, —S(O)2—OH, —C(O)—O− and M+, and S(O)2—O− and M+, with M+ representing a cationic counter-ion such as an alkali metal, alkaline earth metal, or ammonium, and n is 0 or 1. In the hair color-altering compositions containing them, the amino acids and amino sulfonic acids may be in their non-ionized form (I) and (II) or in their ionized or betaine form (I′) and (II′):
wherein “R” and “n” are as defined above. The one or more amino acids and/or amino sulfonic acids may also be in their conjugate base form (Ib) and (IIb).
wherein “R” and “n” are as defined above.
Well-known amino adds include the twenty amino acids that form the proteins of living organisms (standard proteinogenic amino acids): alanine, arginine, asparagine, aspartic add, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine. The amino acids of the instant disclosure, however, are not limited to the standard proteinogenic amino adds.
Non-limiting examples of amino sulfonic acids include aminomethane sulfonic acid, aminoethane sulfonic acid (taurine), aminopropane sulfonic acid, aminobutane sulfonic acid, aminohexane sulfonic acid, aminoisopropyl sulfonic acid, aminododecyl sulfonic acid, aminobenzene sulfonic acid, aminotoulene sulfonic acid, sulfanilic acid, chlorosulfanilic acid, diamino benzene sulfonic acid, amino phenol sulfonic acid, amino propyl benzene sulfonic acid, amino hexyl benzene sulfonic acid, and a mixture thereof.
In some cases, charged amino acids may be used. Non-limiting examples of charged amino acids include arginine, lysine, aspartic acid, and glutamic acid. In some cases, polar amino acids are useful. Non-limiting examples of polar amino acids include glutamine, asparagine, histidine, serine, threonine, tyrosine, cysteine, methionine, and tryptophan.
In some cases, hydrophobic amino acids may be employed. Non-limiting examples of hydrophobic amino acids include alanine, isoleucine, leucine, phenylalanine, valine, proline, and glycine.
In some instances, the hair color-altering compositions include at least one amino acid or an amino sulfonic acid, and/or a salt thereof, selected from the group consisting of glycine, alanine, serine, beta-alanine, taurine, sodium glycinate, sodium alaninate, sodium serinate, lithium beta-alanine, sodium taurate, and a mixture thereof.
In some cases, the hair color-altering compositions include only amino acid(s) and/or salt(s) thereof, only sulfonic acid(s) and/or salt(s) thereof, or a mixture of both amino acids and sulfonic acids, and/or salts thereof, for example, one or more amino acids and one or more amino sulfonic acids, and/or salts thereof, for example, those selected from the group consisting of aspartic acid, cysteine, glycine, lysine, methionine, proline, tyrosine, phenylalanine, carnitine, taurine, a salt thereof, and a mixture thereof.
In some cases, the hair color-altering compositions include at least taurine (2-aminoethane sulfonic acid) and/or a salt thereof.
The total amount of the at least one amino acid or amino sulfonic acid, and/or salt thereof, is at least 0.01 wt. %, based on the total weight of the hair color-altering composition. The total amount of the at least one amino acid or amino sulfonic acid, and/or salt thereof, may be from about 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 1, 2, 3, 4, 5, 6, 7, 8 or 9 wt. % to about 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 wt. % of the total composition. For example, the at least one amino acid or amino sulfonic acid and/or a salt thereof may be present from about 0.01 wt. % to about 10 wt. % of the total composition, or more particularly from about 0.01 wt. % to about 5 wt. % of the total composition.
Carboxylic Acid
The hair color-altering compositions may include at least one carboxylic acid, and/or a salt thereof, typically in an amount of at least 0.01 wt. %, based on the total weight of the hair color-altering composition.
A non-polymeric mono, di, and/or tricarboxylic acid is an organic compound having one (mono), two (di), or three (tri) carboxylic acid groups (—COOH). The non-polymeric mono, di, and tricarboxylic acids, and/or salts thereof, typically have a molecular weight of less than about 500 g/mol, less than about 400 g/mol, or less than about 300 g/mol.
Non-limiting examples of mono-carboxylic acids, or salts thereof, include formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, entanthic acid, caprylic acid, pelargonic acid, capric acid, undecylic acid, lauric acid, tridecylic acid, lauric acid, tridecylic acid, myristic acid, pentadecylic acid, palmitic acid, margaric acid, stearic acid, nonadecylic acid, arachidic acid, lactic acid, a salt thereof, and a mixture thereof. In some cases, the hair color-altering compositions include at least lactic acid and/or a salt thereof.
Non-limiting examples of di-carboxylic acids and/or salts thereof include oxalic acid, malonic acid, malic acid, glutaric acid, citraconic acid, succinic acid, adipic acid, tartaric acid, fumaric acid, maleic acid, sebacic acid, azelaic acid, dodecanedioic acid, phthalic acid, isophthalic acid, terephthalic acid, 2,6-naphthalene dicarboxylic acid, a salt thereof, and a mixture thereof. In some cases, the hair color-altering compositions include oxalic acid, malonic acid, malic acid, maleic acid, a salt thereof, or a mixture thereof.
Non-limiting examples of tricarboxylic acids and salts thereof include citric acid, isocitric acid, aconitric acid, propane-1,2,3-tricarboxylic acid, benzene-1,3,5-tricarboxylic acid, a salt thereof, and a mixture thereof. In some instances, the hair color-altering compositions include at least citric acid and/or a salt thereof.
In one or more embodiments, the hair color-altering composition comprise at least one carboxylic acid selected from the group consisting of oxalic acid, malonic acid, glutaric acid, succinic acid, adipic acid, glycolic acid, citric acid, tartaric acid, malic acid, sebacic acid, maleic acid, fumaric acid, benzoic acid, citraconic acid, aconitic acid, propane-1,2,3-tricarboxylic acid, trimesic acid, and combinations thereof.
The total amount of the at least one non-polymeric mono, di, or tricarboxylic acid, and/or a salt thereof, is at least 0.01 wt. %, based on the total weight of the hair color-altering composition. In some cases, the total amount of the at least one non-polymeric mono, di, or tricarboxylic acid, and/or salt thereof, ranges from about 0.01, 0.02, 0.03, 0.04, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, 5, 6, 7, 8 or 9 wt. % to about 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 wt. % by total weight of the composition.
Hair Color-Altering Agent
The hair color-altering compositions may comprise a hair color-altering agent selected from the group consisting of oxidizing agents, oxidative dyes, direct dyes.
In embodiments comprising oxidizing agents, the at least one oxidizing agent may be chosen, for example, from peroxides, persulfates, perborates, percarbonates, alkali metal bromates, ferricyanides, peroxygenated salts, alkali metal carbonates, or a mixture thereof. Oxidizing agents that may also be used include at least one redox enzyme such as laccases, peroxidases, and 2-electron oxidoreductases, such as uricase, where appropriate in the presence of their respective donor or co-factor. Oxygen in the air may also be employed as an oxidizing agent.
In one embodiment, the oxidizing agent can be hydrogen peroxide present in an aqueous solution whose titer may range from 1 to 40 volumes, such as from 5 to 40 volumes or such as from 5 to 20 volumes.
In another embodiment, the oxidizing agent can be a persulfate and/or a monopersulfate such as, for example, potassium persulfate, sodium persulfate, ammonium persulfate, as well as mixtures thereof. In one embodiment, the oxidizing agents in the present disclosure are selected from hydrogen peroxide, potassium persulfate, sodium persulfate, and mixtures thereof. In certain embodiments, the oxidizing agent is hydrogen peroxide.
In general, the oxidizing agent will be present in an amount ranging from about 0.05 to about 50% by weight, such as from about 0.1% to about 30% by weight, from about 0.1% to about 20% by weight, or from about 1% to about 10% by weight, based on the total weight of the developer composition or solution or system in which it is present.
In embodiments comprising oxidation dyes, the oxidation dyes are generally chosen from one or more oxidation bases optionally combined with one or more couplers. By way of example, the oxidation bases may be chosen from para-phenylenediamines, bis(phenyl)alkylenediamines, para-aminophenols, ortho-aminophenols and heterocyclic bases, and the addition salts thereof.
Among the para-phenylenediamines that may be mentioned, for example, are para-phenylenediamine, para-toluenediamine, 2-chloro-para-phenylenediamine, 2,3-dimethyl-para-phenylenediamine, 2,6-dimethyl-para-phenylenediamine, 2,6-diethyl-para-phenylenediamine, 2,5-dimethyl-para-phenylenediamine, N,N-dimethyl-para-phenylenediamine, N,N-diethyl-para-phenylenediamine, N,N-dipropyl-para-phenylenediamine, 4-amino-N,N-diethyl-3-methylaniline, N,N-bis(β-hydroxyethyl)-para-phenylenediamine, 4-N,N-bis(β-hydroxyethyl)amino-2-methylaniline, 4-N,N-bis(β-hydroxyethyl)amino-2-chloroaniline, 2-β-hydroxyethyl-para-phenylenediamine, 2-methoxymethyl-para-phenylenediamine, 2-fluoro-para-phenylenediamine, 2-isopropyl-para-phenylenediamine, N-(β-hydroxypropyl)-para-phenylenediamine, 2-hydroxymethyl-para-phenylenediamine, N,N-dimethyl-3-methyl-para-phenylenediamine, N-ethyl-N-(β-hydroxyethyl)-para-phenylenediamine, N-(β,γ-dihydroxypropyl)-para-phenylenediamine, N-(4′-aminophenyl)-para-phenylenediamine, N-phenyl-para-phenylenediamine, 2-β-hydroxyethyloxy-para-phenylenediamine, 2-β-acetylaminoethyloxy-para-phenylenediamine, N-(β-methoxyethyl)-para-phenylenediamine, 4-aminophenylpyrrolidine, 2-thienyl-para-phenylenediamine, 2-β-hydroxyethylamino-5-aminotoluene and 3-hydroxy-1-(4′-aminophenyl)pyrrolidine, and the addition salts thereof with an acid.
Among the para-phenylenediamines mentioned above, para-phenylenediamine, para-toluenediamine, 2-isopropyl-para-phenylenediamine, 2-β-hydroxyethyl-para-phenylenediamine, 2-β-hydroxyethyloxy-para-phenylenediamine, 2,6-dimethyl-para-phenylenediamine, 2,6-diethyl-para-phenylenediamine, 2,3-dimethyl-para-phenylenediamine, N,N-bis(β-hydroxyethyl)-para-phenylenediamine, 2-chloro-para-phenylenediamine and 2-β-acetylaminoethyloxy-para-phenylenediamine, and the addition salts thereof with an acid, are particularly preferred.
Among the bis(phenyl)alkylenediamines that may be mentioned, for example, are N,N′-bis(β-hydroxyethyl)-N,N′-bis(4′-aminophenyl)-1,3-diaminopropanol, N,N′-bis(β-hydroxyethyl)-N,N′-bis(4′-aminophenyl)ethylenediamine, N,N′-bis(4-aminophenyl)tetramethylenediamine, N,N′-bis(β-hydroxyethyl)-N,N′-bis(4-aminophenyl)tetramethylenediamine, N,N′-bis(4-methylaminophenyl)tetramethylenediamine, N,N′-bis(ethyl)-N,N′-bis(4′-amino-3′-methylphenyl)ethylenediamine and 1,8-bis(2,5-diaminophenoxy)-3,6-dioxaoctane, and the addition salts thereof.
Among the para-aminophenols that may be mentioned, for example, are para-aminophenol, 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 4-amino-3-chlorophenol, 4-amino-3-hydroxymethylphenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethylphenol, 4-amino-2-aminomethylphenol, 4-amino-2-(β-hydroxyethylaminomethyl)phenol and 4-amino-2-fluorophenol, and the addition salts thereof with an acid.
Among the ortho-aminophenols that may be mentioned, for example, are 2-aminophenol, 2-amino-5-methylphenol, 2-amino-6-methylphenol and 5-acetamido-2-aminophenol, and the addition salts thereof.
Among the heterocyclic bases that may be mentioned, for example, are pyridine derivatives, pyrimidine derivatives and pyrazole derivatives.
Among the pyridine derivatives that may be mentioned are the compounds described, for example, in patents GB 1 026 978 and GB 1 153 196, for instance 2,5-diaminopyridine, 2-(4-methoxyphenyl)amino-3-aminopyridine and 3,4-diaminopyridine, and the addition salts thereof.
Other pyridine oxidation bases can include the 3-aminopyrazolo[1,5-a]pyridine oxidation bases or the addition salts thereof described, for example, in patent application FR 2 801 308. Examples that may be mentioned include pyrazolo[1,5-a]pyrid-3-ylamine, 2-acetylaminopyrazolo[1,5-a]pyrid-3-ylamine, 2-morpholin-4-ylpyrazolo[1,5-a]pyrid-3-ylamine, 3-aminopyrazolo[1,5-a]pyridine-2-carboxylic acid, 2-methoxypyrazolo[1,5-a]pyrid-3-ylamine, (3-aminopyrazolo[1,5-a]pyrid-7-yl)methanol, 2-(3-aminopyrazolo[1,5-a]pyrid-5-yl)ethanol, 2-(3-aminopyrazolo[1,5-a]pyrid-7-yl)ethanol, (3-aminopyrazolo[1,5-a]pyrid-2-yl)methanol, 3,6-diaminopyrazolo[1,5-a]pyridine, 3,4-diaminopyrazolo[1,5-a]pyridine, pyrazolo[1,5-a]pyridine-3,7-diamine, 7-morpholin-4-ylpyrazolo[1,5-a]pyrid-3-ylamine, pyrazolo[1,5-a]pyridine-3,5-diamine, 5-morpholin-4-ylpyrazolo[1,5-a]pyrid-3-ylamine, 2-[(3-aminopyrazolo[1,5-a]pyrid-5-yl)(2-hydroxyethyl)amino]ethanol, 2-[(3-aminopyrazolo[1,5-a]pyrid-7-yl)(2-hydroxyethyl)amino]ethanol, 3-aminopyrazolo[1,5-a]pyridin-5-ol, 3-aminopyrazolo[1,5-a]pyridin-4-ol, 3-aminopyrazolo[1,5-a]pyridin-6-ol, 3-aminopyrazolo[1,5-a]pyridin-7-ol, 2-□-hydroxyethoxy-3-amino-pyrazolo[1,5-a]pyridine; 2-(4-dimethylpyperazinium-1-yl)-3-amino-pyrazolo[1,5-a]pyridine; and the addition salts thereof.
More particularly, oxidation bases can be selected from 3-aminopyrazolo-[1,5-a]-pyridines and preferably substituted on carbon atom 2 by:
Among the pyrimidine derivatives that may be mentioned are the compounds described, for example, in the patents DE 2359399; JP 88-169571; JP 05-63124; EP 0770375 or patent application WO 96/15765, such as 2,4,5,6-tetraaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine, 2,5,6-triaminopyrimidine and their addition salts and their tautomeric forms, when a tautomeric equilibrium exists.
Among the pyrazole derivatives that may be mentioned are the compounds described in the patents DE 3843892, DE 4133957 and patent applications WO 94/08969, WO 94/08970, FR-A-2 733 749 and DE 195 43 988, such as 4,5-diamino-1-methylpyrazole, 4,5-diamino-1-(β-hydroxyethyl)pyrazole, 3,4-diaminopyrazole, 4,5-diamino-1-(4′-chlorobenzyl)pyrazole, 4,5-diamino-1,3-dimethylpyrazole, 4,5-diamino-3-methyl-1-phenylpyrazole, 4,5-diamino-1-methyl-3-phenylpyrazole, 4-amino-1,3-dimethyl-5-hydrazinopyrazole, 1-benzyl-4,5-diamino-3-methylpyrazole, 4,5-diamino-3-tert-butyl-1-methylpyrazole, 4,5-diamino-1-tert-butyl-3-methylpyrazole, 4,5-diamino-1-(β-hydroxyethyl) -3-methylpyrazole, 4,5-diamino-1-ethyl-3-methylpyrazole, 4,5-diamino-1-ethyl-3-(4′-methoxyphenyl)pyrazole, 4,5-diamino-1-ethyl-3-hydroxymethylpyrazole, 4,5-diamino-3-hydroxymethyl-1-methylpyrazole, 4,5-diamino-3-hydroxymethyl-1-isopropyl-pyrazole, 4,5-diamino-3-methyl-1-isopropylpyrazole, 4-amino-5-(2′-aminoethyl)amino -1,3-dimethylpyrazole, 3,4,5-triaminopyrazole, 1-methyl-3,4,5-triaminopyrazole, 3,5-diamino-1-methyl-4-methylaminopyrazole, 3,5-diamino-4-(β-hydroxyethyl)amino-1-methylpyrazole, and the addition salts thereof. 4,5-Diamino-1-(β-methoxyethyl)pyrazole may also be used. A 4,5-diaminopyrazole will preferably be used, and even more preferentially 4,5-diamino-1-(β-hydroxyethyl)pyrazole and/or a salt thereof.
Pyrazole derivatives that may also be mentioned include diamino-N,N-dihydro-pyrazolopyrazolones and especially those described in patent application FR-A-2 886 136, such as the following compounds and the addition salts thereof: 2,3-diamino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one, 2-amino-3-ethylamino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one, 2-amino-3-isopropylamino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one, 2-amino-3-(pyrrolidin-1-yl)-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one, 4,5-diamino-1,2-dimethyl-1,2-dihydropyrazol-3-one, 4,5-diamino-1,2-diethyl-1,2-dihydropyrazol-3-one, 4,5-diamino-1,2-di-(2-hydroxyethyl)-1,2-dihydropyrazol-3-one, 2-amino-3-(2-hydroxyethyl)amino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one, 2-amino-3-dimethylamino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one, 2,3-diamino-5,6,7,8-tetrahydro-1H,6H-pyridazino[1,2-a]pyrazol-1-one, 4-amino-1,2-diethyl-5-(pyrrolidin-1-yl)-1,2-dihydropyrazol-3-one, 4-amino-5-(3-dimethylaminopyrrolidin-1-yl)-1,2-diethyl-1,2-dihydropyrazol-3-one, 2,3-diamino-6-hydroxy-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one.
2,3-Diamino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one and/or a salt thereof will preferably be used.
4,5-Diamino-1-(β-hydroxyethyl)pyrazole and/or 2,3-diamino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one and/or a salt thereof will preferentially be used as heterocyclic bases.
Compositions and/or systems according to embodiments of the disclosure may optionally further comprise one or more couplers advantageously chosen from those conventionally used in the dyeing or coloring of keratinous substrates.
Among these couplers, mention may be made especially of meta-phenylenediamines, meta-aminophenols, meta-diphenols, naphthalene-based couplers and heterocyclic couplers, and also the addition salts thereof.
Mention may be made, for example, of 2-methyl-5-aminophenol, 5-N-(β-hydroxyethyl)amino-2-methylphenol, 3-aminophenol, 5-amino-6-chloro-o-cresol (3-amino-2-chloro-6-methylphenol), 1,3-dihydroxybenzene, 1,3-dihydroxy-2-methyl-benzene, 4-chloro-1,3-dihydroxybenzene, 2,4-diamino-1-(β-hydroxyethyloxy)benzene, 2-amino-4-(β-hydroxyethylamino)-1-methoxybenzene, 1,3-diaminobenzene, 1,3-bis(2,4-diaminophenoxy)propane, 3-ureidoaniline, 3-ureido-1-dimethylaminobenzene, sesamol, 1-β-hydroxyethylamino-3,4-methylenedioxybenzene, α-naphthol, 2-methyl-1-naphthol, 6-hydroxyindole, 4-hydroxyindole, 4-hydroxy-N-methylindole, 2-amino-3-hydroxypyridine, 6-hydroxybenzomorpholine, 3,5-diamino-2,6-dimethoxypyridine, 1-N-(β-hydroxyethyl)amino-3,4-methylenedioxybenzene, 2,6-bis(β-hydroxyethylamino)-toluene, 6-hydroxyindoline, 2,6-dihydroxy-4-methylpyridine, 1-H-3-methylpyrazol-5-one, 1-phenyl-3-methylpyrazol-5-one, 2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole, 2,6-dimethyl[3,2-c]-1,2,4-triazole and 6-methylpyrazolo[1,5-a]benzimidazole, the addition salts thereof with an acid, and mixtures thereof.
In general, the addition salts of the oxidation bases and couplers that may be used in the context of the invention are especially selected from the addition salts with an acid such as the hydrochlorides, hydrobromides, sulfates, citrates, succinates, tartrates, lactates, tosylates, benzenesulfonates, phosphates and acetates.
The oxidation base(s) may be present in an amount ranging from about 0.001% to 10% by weight, such as from about 0.005% to 5% by weight, relative to the total weight of the system or composition comprising the system in which it is present.
The coupler(s), if they are present, may be present in an amount ranging from about 0.001% to 10% by weight, such as from about 0.005% to 5% by weight, relative to the total weight of the system or composition comprising the system in which it is present.
Compositions according to embodiments of the disclosure may optionally comprise one or more synthetic or natural direct dyes, for example chosen from anionic and nonionic species, preferably cationic or nonionic species, either as sole dyes or in addition to the oxidation dye(s).
Examples of suitable direct dyes that may be mentioned include azo direct dyes; (poly)methine dyes such as cyanins, hemicyanins and styryls; carbonyl dyes; azine dyes; nitro(hetero)aryl dyes; tri(hetero)arylmethane dyes; porphyrin dyes; phthalocyanin dyes, and natural direct dyes, alone or as mixtures.
Preferably direct dyes are cationic direct dyes. Mention may be made of the hydrazono cationic dyes of formulas (Va) and (V′a), the azo cationic dyes (VIa) and (VI′a) and the diazo cationic dyes (VIIa) below:
in which formulas (Va), (V′a), (VIa), (VI′a) and (VIIa):
or alternatively the substituent Ra with a substituent of Het+ and/or Rb with a substituent of Ar and/or Ra with Rb form, together with the atoms that bear them, a (hetero)cycloalkyl;
particularly, Ra and Rb represent a hydrogen atom or a group (C1-C4)alkyl, which is optionally substituted with a hydroxyl group;
In particular, mention may be made of the azo and hydrazono cationic dyes bearing an endocyclic cationic charge of formulae (Va), (V′a) and (Via) as defined previously. More particularly those of formulae (Va), (V′a) and (Via) derived from the dyes described in patent applications WO 95/15144, WO 95/01772 and EP-714954.
Preferentially, the cationic part is derived from the following derivatives:
formulae (V-1) and (VI-1) with:
Among the natural direct dyes, mention may be made of lawsone, juglone, alizarin, purpurin, carminic acid, kermesic acid, purpurogallin, protocatechaldehyde, indigo, isatin, curcumin, spinulosin, apigenidin and orceins. Extracts or decoctions containing these natural dyes and in particular henna-based poultices or extracts may also be used.
When they are present, the one or more direct dyes more particularly represent from about 0.001% to 10% by weight, such as from about 0.005% to 5% by weight, of the total weight of the system or composition comprising the system in which it is present.
Alkalizing Agents
In some embodiments, the hair-color altering composition comprises an alkalizing agent. The alkalizing agent the present invention may be chosen from organic amines, organic amine salts, ammonium salts, inorganic bases, and hydroxide base compounds.
The organic amines may be chosen from the ones having a pKb at 25° C. of less than 12, such as less than 10 or such as less than 6. It should be noted that this is the pKb corresponding to the function of highest basicity.
Organic amines may be chosen from organic amines comprising one or two primary, secondary, or tertiary amine functions, and at least one linear or branched C1-C8 alkyl groups bearing at least one hydroxyl radical.
Organic amines may also be chosen from alkanolamines such as mono-, di- or trialkylamines, comprising one to three identical or different C1-C4 hydroxyalkyl radicals, ethylamines, ethyleneamines, quinoline, aniline and cyclic amines, such as pyrroline, pyrrole, pyrrolidine, imidazole, imidazolidine, imidazolidinine, morpholine, pyridine, piperidine, pyrimidine, piperazine, triazine and derivatives thereof.
Among the compounds of the alkanolamine type that may be mentioned include but not limited to: monoethanolamine (also known as monoethanolamine or MEA), diethanolamine, triethanolamine, monoisopropanolamine, diisopropanolamine, N-dimethylaminoethanolamine, 2-amino-2-methyl-1-propanol, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 3-amino-1,2-propanediol, 3-dimethylamino-1,2-propanediol, 2-amino-2-methyl-1-propanol, and tris(hydroxymethylamino)methane.
Other organic amines correspond to the formula (IV):
wherein W is chosen from C1-C6 alkylene residues optionally substituted with a hydroxyl group or a C1-C6 alkyl radical; Rx, Ry, Rz and Rt, which may be identical or different, are chosen from a hydrogen atom, C1-C6 alkyl radicals, C1-C6 hydroxyalkyl radicals, and C1-C6 aminoalkyl radicals.
Examples of such amines that may be mentioned include but not limited to: 1,3-diaminopropane, 1,3-diamino-2-propanol, spermine, and spermidine.
In some embodiments, the organic amines are chosen from amino acids.
As non-limiting examples, the amino acids that may be used may be of natural or synthetic origin, in L, D, or racemic form, and comprise at least one acid function chosen from, for instance, carboxylic acid, sulfonic acid, phosphonic acid, and phosphoric acid functions. The amino acids may be in their neutral or ionic form.
Further as non-limiting examples, the amino acids may be chosen from basic amino acids comprising an additional amine function optionally included in a ring or in a ureido function.
Such basic amino acids may be chosen from those corresponding to formula (A) below:
wherein R is a group chosen from:
The compounds corresponding to formula (A) may be chosen from histidine, lysine, arginine, ornithine, and citrulline.
Amino acids that may be used in the present disclosure include but not limited to: aspartic acid, glutamic acid, alanine, arginine, ornithine, citrulline, asparagine, carnitine, cysteine, glutamine, glycine, histidine, lysine, isoleucine, leucine, methionine, N-phenylalanine, proline, serine, taurine, threonine, tryptophan, tyrosine, and valine.
In some embodiments, the organic amines are chosen from basic amino acids. The amino acids may be chosen from, for instance, arginine, lysine and histidine, or mixtures thereof.
In some embodiments, the organic amines are chosen from organic amines of heterocyclic type. Besides histidine that has already been mentioned in the amino acids, non-limiting mention may also be made of pyridine, piperidine, imidazole, 1,2,4-triazole, tetrazole, and benzimidazole.
In some embodiments, the organic amines are chosen from amino acid dipeptides. Amino acid dipeptides that may be used in the present disclosure include but not limited to: carnosine, anserine, and baleine.
In some embodiments, the organic amines are chosen from compounds comprising a guanidine function. Organic amines of this type that may be used in the present disclosure include, besides arginine that has already been mentioned as an amino acid, creatine, creatinine, 1,1-dimethylguanidine, 1,1-diethylguanidine, glycocyamine, metformin, agmatine, N-amidinoalanine, 3-guanidinopropionic acid, 4-guanidinobutyric acid, and 2-([amino(imino)methyl]amino)ethane-1-sulfonic acid.
As a non-limiting example, the organic amines are chosen from alkanolamines. For example, the organic amines are chosen from ethanolamine, triethanoloamine, 2-amino-2-methyl-1-propanol (amino methyl propanol), or preferably from 2-amino-2-methyl-1-propanol and monoethanolamine, or mixtures thereof. Further as an example, the organic amine is monoethanolamine.
The alkalizing agent may be an organic amine in salt form. The term “organic amine salt,” as used herein, means organic or mineral salts of an organic amine as described above.
As a non-limiting example, the organic salts may be chosen from the salts of organic acids, such as citrates, lactates, glycolates, gluconates, acetates, propionates, fumarates, oxalates and tartrates.
Further as a non-limiting example, the mineral salts may be chosen from hydrohalides (for example hydrochlorides), carbonates, hydrogen carbonates, sulfates, hydrogen phosphates, and phosphates.
The ammonium salts that may be used according to the present disclosure may be chosen from the following acid salts: carbonate, bicarbonate. For instance, the salt is the carbonate, such as ammonium carbonate.
The inorganic bases that may be used may be chosen from alkali metal phosphates and carbonates such as, for example, sodium phosphate, potassium phosphate, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, and their derivatives.
The inorganic bases may also include alkali metals of carboxylates such as, for example, sodium acetate, potassium acetate, sodium citrate, and potassium citrate, and their derivatives.
The hydroxide base compounds can be chosen from alkali metal hydroxides, alkaline-earth metal hydroxides, transition metal hydroxides, quaternary ammonium hydroxides, organic hydroxides, and mixtures thereof. Suitable examples are ammonium hydroxide, sodium hydroxide, potassium hydroxide, lithium hydroxide, rubidium hydroxide, caesium hydroxide, francium hydroxide, beryllium hydroxide, magnesium hydroxide, calcium hydroxide, strontium hydroxide, barium hydroxide, molybdenum hydroxide, manganese hydroxide, zinc hydroxide, cobalt hydroxide, cadmium hydroxide, cerium hydroxide, lanthanum hydroxide, actinium hydroxide, thorium hydroxide, aluminium hydroxide, guanidinium hydroxide and mixtures thereof.
According to at least one embodiment, the alkalizing agent is chosen from alkali metal carbonates, alkali metal phosphate, organic amines, hydroxide base compounds, and derivatives thereof.
According to at least one embodiment, the alkalizing agent is chosen from aminomethyl propanol, aminomethyl propanediol, triisopropanol amine sodium hydroxide, potassium hydroxide, ammonium hydroxide, dimethylstearylamine, dimethyl/tallowamine lysine, ornithine, arginine, monoethanolamine, triethanolamine, calcium hydroxide, calcium bicarbonate, sodium bicarbonate, and mixtures thereof
According to one embodiment, the alkalizing agent is chosen from at least one organic amine such as at least one alkanolamine. A particularly preferred alkanolamine is ethanolamine (also known as monoethanolamine or MEA).
According to one embodiment, the alkalizing agent is chosen from at least one hydroxide base compounds, a particularly preferred hydroxide base compounds is ammonium hydroxide,
According to one embodiment, the alkalizing agent comprises ammonium hydroxide and ethanolamine.
The at least one alkalizing agent of the present invention may be employed in an amount of from about 2% to about 20% by weight, such as from about 2% to about 11% by weight, and further such as from about 4.5% to about 10% by weight, based on the total weight of the hair color composition of the present invention, including increments and ranges therein there between.
The total amount of the alkalizing agent in the present invention may be employed in an amount of from about 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, to about 20 percent by weight, including increments and ranges therein there between.
The amount of the alkalizing agent in the composition can be such that the pH of the composition can be neutral or alkaline range pH above 7.
According to at least one embodiment, the compositions or compositions for altering the color of keratin fibers of the present invention contain a small amount (i.e., greater than 0 but less than 8, 7, 6, 5, 4, 3 or 2% by weight) of ammonia, or is substantially free of ammonia.
According to another embodiment, the compositions or compositions for altering the color of keratin fibers of the present invention contain ammonia/ammonium hydroxide in an amount such that it is used as the alkalizing agent in the compositions.
Fatty Substances
Fatty substances (also referred to interchangeably as “fatty compounds”) may be included in one or more embodiments of the invention. In some embodiments, two or more fatty substances may be included. In further embodiments, such fatty substances may be a fatty substance other than a fatty acid. As used herein, “fatty substance” means an organic compound insoluble in water at normal temperature (25° C.) and at atmospheric pressure (760 mmHg) (solubility below 5% and such as below 1% and further such as below 0.1%). Fatty substances have in their structure a chain of at least two siloxane groups or at least one hydrocarbon chain having at least 6 carbon atoms. Moreover, fatty substances are generally soluble in organic solvents in the same conditions of temperature and pressure, for example in chloroform, ethanol, benzene or decamethylcyclopentasiloxane.
Fatty substances are, for example, chosen from lower alkanes, fatty alcohols, esters of fatty acid, esters of fatty alcohol, oils such as mineral, vegetable, animal and synthetic non-silicone oils, non-silicone waxes and silicones.
In some embodiments, the alcohols and esters have at least one linear or branched, saturated or unsaturated hydrocarbon group, comprising 6 to 30 carbon atoms, optionally substituted, for example, with at least one hydroxyl group (for example 1 to 4). If they are unsaturated, these compounds can have one to three, conjugated or unconjugated, carbon-carbon double bonds.
With regard to the lower alkanes, in some embodiments, these have from 6 to 16 carbon atoms and are linear or branched, optionally cyclic. As examples, alkanes can be chosen from hexane and dodecane, isoparaffins such as isohexadecane and isodecane.
Non-limiting examples of non-silicone oils usable in the composition of the disclosure, include: esters of a glycerol oligomer, in particular diglycerol esters, especially condensates of adipic acid and of glycerol, for which a portion of the hydroxyl groups of the glycerols has reacted with a mixture of fatty acids, such as stearic acid, capric acid, isostearic acid and 12-hydroxystearic acid, such as in particular those sold under the brand name Softisan 649 by Sasol; arachidyl propionate, sold under the brand name Waxenol 801 by Alzol; fatty acid triglycerides and their derivatives; pentaerythritol esters; esters of dimer diol and dimer diacid, if appropriate esterified on their free alcohol or acid functional group(s) by acid or alcohol radicals, in particular dimer dilinoleate esters; such esters can be chosen in particular from esters with the following INCI nomenclature: bis-behenyl/isostearyl/phytosteryl dimer dilinoleyl dimer dilinoleate (Plandool G), phytosteryl isostearyl dimer dilinoleate (Lusplan PI-DA or Lusplan PHY/IS-DA), phytosteryl/isostearyl/cetyl/stearyl/behenyl dimer dilinoleate (Plandool H or Plandool S), and their mixtures; mango butter, such as that sold under the reference Lipex 203 by AarhusKarlshamn; hydrogenated soybean oil, hydrogenated coconut oil, hydrogenated rapeseed oil or mixtures of hydrogenated vegetable oils, such as the soybean, coconut, palm and rapeseed hydrogenated vegetable oil mixture, for example the mixture sold under the reference Akogel® by AarhusKarlshamn (INCI name: Hydrogenated Vegetable Oil); shea butter, in particular that having the INCI name Butyrospermum Parkii Butter, such as that sold under the reference Sheasoft® by AarhusKarlshamn; cocoa butter, in particular that which is sold under the name CT Cocoa Butter Deodorized by Dutch Cocoa BV or that which is sold under the name Beurre De Cacao NCB HD703 758 by Barry Callebaut; shorea butter, in particular that which is sold under the name Dub Shorea T by Stearinerie Dubois; and their mixtures.
According to a preferred embodiment, the fatty substance is chosen from hydrogenated vegetable oil, shea butter, cocoa butter, shorea butter, a soybean, coconut, palm and rapeseed hydrogenated vegetable oil mixture, and their mixtures, and more particularly those referenced above.
Non-limiting examples of non-silicone oils usable in the composition of the disclosure, include: hydrocarbon oils of animal origin, such as perhydrosqualene; hydrocarbon oils of vegetable origin, such as liquid triglycerides of fatty acids having from 6 to 30 carbon atoms such as triglycerides of heptanoic or octanoic acids, or for example sunflower oil, maize oil, soya oil, cucurbit oil, grapeseed oil, sesame oil, hazelnut oil, apricot oil, macadamia oil, arara oil, sunflower oil, castor oil, avocado oil, triglycerides of caprylic/capric acids such as those sold by the company Stearineries Dubois or those sold under the names MIGLYOL® 810, 812 and 818 by the company Dynamit Nobel, jojoba oil, shea butter oil; hydrocarbons with more than 16 carbon atoms, linear or branched, of mineral or synthetic origin, such as paraffin oils, petroleum jelly, liquid paraffin, polydecenes, hydrogenated polyisobutene such as Parleam®. fluorinated, partially hydrocarbon oils; as fluorinated oils, non-limiting examples include perfluoromethylcyclopentane and perfluoro-1,3-dimethylcyclohexane, sold under the names “FLUTEC® PC1” and “FLUTEC® PC3” by the company BNFL Fluorochemicals; perfluoro-1,2-dimethylcyclobutane; perfluoroalkanes such as dodecafluoropentane and tetradecafluorohexane, sold under the names “PF 5050®” and “PF 5060®” by the 3M Company, or bromoperfluorooctyl sold under the name “FORALKYL®” by the company Atochem; nonafluoro-methoxybutane and nonafluoroethoxyisobutane; derivatives of perfluoromorpholine, such as 4-trifluoromethyl perfluoromorpholine sold under the name “PF 5052®” by the 3M Company. The non-silicone oils of the present invention may be employed in an amount of from about 0.5% to about 5% by weight, such as from about 1% to about 5.5% by weight, and further such as from about 1.5% to about 4% by weight, based on the total weight of the hair color composition of the present invention, including increments and ranges therein there between.
The total amount of the non-silicone oils in the present invention may be employed in an amount of from about 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, to about 5 percent by weight, including increments and ranges therein there between.
As used herein, “fatty alcohol” refers to any alcohol with a carbon chain of C5 or greater, such as, for example, C8 or greater, C10 or greater, and C12 or greater. The at least one fatty alcohol may be chosen from, for example, C9-C11 alcohols, C12-C13 alcohols, C12-C15 alcohols, C12-C16 alcohols, C14-C15 alcohols, arachidyl alcohol, behenyl alcohol, caprylic alcohol, cetearyl alcohol, cetyl alcohol, coconut alcohol, decyl alcohol, hydrogenated tallow alcohol, jojoba alcohol, lauryl alcohol, myristyl alcohol, oleyl alcohol, palm alcohol, palm kernel alcohol, stearyl alcohol, tallow alcohol, and tridecyl alcohol.
As used herein, “alkoxylated fatty alcohol” refers to any fatty alcohol with a carbon chain of C5 or greater, as defined above, further comprising at least one alkoxy group. For example, the at least one alkoxylated fatty alcohol may have a carbon chain of C8 or greater, C10 or greater, and C12 or greater. Further, for example, the at least one alkoxylated fatty alcohol may be chosen from alkoxylated polymers (including co-, ter- and homo-polymers) derived from alcohols such as glycerol (e.g. polyglyceryl derived from four glycerol molecules). The at least one alkoxy group of the at least one alkoxylated fatty alcohol may, for example, be derived from an alkoxylation reaction carried out with alkylene oxide. Non-limiting examples of at least one alkoxylated fatty alcohol include any fatty alcohol comprising at least one polyethylene glycol ether and any fatty alcohol comprising at least one polypropylene glycol ether.
Non-limiting examples of the at least one alkoxylated fatty alcohol include ceteareth-2, ceteareth-3, ceteareth-4, ceteareth-5, ceteareth-6, ceteareth-7, ceteareth-8, ceteareth-9, ceteareth-10, ceteareth-11, ceteareth-12, ceteareth-13, ceteareth-14, ceteareth-15, ceteareth-16, ceteareth-17, ceteareth-18, ceteareth-20, ceteareth-22, ceteareth-23, ceteareth-24, ceteareth-25, ceteareth-27, ceteareth-28, ceteareth-29, ceteareth-30, ceteareth-33, ceteareth-34, ceteareth-40, ceteareth-50, ceteareth-55, ceteareth-60, ceteareth-80, ceteareth-100, laureth-1, laureth-2, laureth-3, laureth-4, laureth-5, laureth-6, laureth-7, laureth-8, laureth-9, laureth-10, laureth-11, laureth-12, laureth-13, laureth-14, laureth-15, laureth-16, laureth-20, laureth-23, laureth-25, laureth-30, laureth-40, deceth-3, deceth-5, oleth-5, oleth-30, steareth-2, steareth-10, steareth-20, steareth-100, cetylsteareth-12, ceteareth-5, ceteareth-5, polyglyceryl 4-lauryl ether, polyglyceryl 4-oleyl ether, polyglyceryl 2-oleyl ether, polyglyceryl 2-cetyl ether, polyglyceryl 6-cetyl ether, polyglyceryl 6-oleylcetyl ether, polyglyceryl 6-octadecyl ether, C9-C11 pareth-3, C9-C11 pareth-6, C11-C15 pareth-3, C11-C15 pareth-5, C11-C15 pareth-12, C 11-C15 pareth-20, C12-C15 pareth-9, C12-C15 pareth-12, and C22-C24 pareth-33.
The fatty alcohols usable as fatty substances in the composition of the disclosure include, but are not limited to, non-alkoxylated, saturated or unsaturated, linear or branched, and have from 6 to 30 carbon atoms and more particularly from 8 to 30 carbon atoms; For example, cetyl alcohol, stearyl alcohol and their mixture (cetylstearyl alcohol), octyldodecanol, 2-butyloctanol, 2-hexyldecanol, 2-undecylpentadecanol, oleic alcohol or linoleic alcohol.
The exemplary non-silicone wax or waxes that can be used in the composition of the disclosure are chosen from carnauba wax, candelilla wax, and Alfa wax, paraffin wax, ozokerite, vegetable waxes such as olive wax, rice wax, hydrogenated jojoba wax or absolute waxes of flowers such as the essential wax of blackcurrant flower sold by the company BERTIN (France), animal waxes such as beeswaxes, or modified beeswaxes (cerabellina); other waxes or waxy raw materials usable according to the disclosure are, for example, marine waxes such as that sold by the company SOPHIM under reference M82, waxes of polyethylene or of polyolefins in general.
The exemplary fatty acid esters are the esters of saturated or unsaturated, linear or branched C1-C26 aliphatic mono- or polyacids and of saturated or unsaturated, linear or branched C1-C26 aliphatic mono- or polyalcohols, the total number of carbons of the esters being, for example, greater than or equal to 10.
Among the monoesters, non-limiting mentions can be made of dihydroabietyl behenate; octyldodecyl behenate; isocetyl behenate; cetyl lactate; C12-C15 alkyl lactate; isostearyl lactate; lauryl lactate; linoleyl lactate; oleyl lactate; (iso)stearyl octanoate; isocetyl octanoate; octyl octanoate; cetyl octanoate; decyl oleate; isocetyl isostearate; isocetyl laurate; isocetyl stearate; isodecyl octanoate; isodecyl oleate; isononyl isononanoate; isostearyl palmitate; methyl acetyl ricinoleate; myristyl stearate; octyl isononanoate; 2-ethylhexyl isononate; octyl palmitate; octyl pelargonate; octyl stearate; octyldodecyl erucate; oleyl erucate; ethyl and isopropyl palmitates, ethyl-2-hexyl palmitate, 2-octyldecyl palmitate, alkyl myristates such as isopropyl, butyl, cetyl, 2-octyldodecyl, mirystyl, stearyl myristate, hexyl stearate, butyl stearate, isobutyl stearate; dioctyl malate, hexyl laurate, and 2-hexyldecyl laurate.
Further non-limiting mentions of esters can be made of the esters of C4-C22 di- or tricarboxylic acids and of C1-C22 alcohols and the esters of mono-, di- or tricarboxylic acids and of C2-C26 di-, tri-, tetra- or pentahydroxy alcohols.
Even further non-limiting examples of esters include: diethyl sebacate; diisopropyl sebacate; diisopropyl adipate; di-n-propyl adipate; dioctyl adipate; diisostearyl adipate; dioctyl maleate; glyceryl undecylenate; octyldodecyl stearoyl stearate; pentaerythrityl monoricinoleate; pentaerythrityl tetraisononanoate; pentaerythrityl tetrapelargonate; pentaerythrityl tetraisostearate; pentaerythrityl tetraoctanoate; propylene glycol dicaprylate; propylene glycol dicaprate, tridecyl erucate; triisopropyl citrate; triisotearyl citrate; glyceryl trilactate; glyceryl trioctanoate; trioctyldodecyl citrate; trioleyl citrate, propylene glycol dioctanoate; neopentyl glycol diheptanoate; diethylene glycol diisanonate; glycol distearates; and polyethylene glycol distearates.
Among the esters mentioned above, exemplary esters include ethyl, isopropyl, myristyl, cetyl, stearyl palmitates, ethyl-2-hexyl palmitate, 2-octyldecyl palmitate, alkyl myristates such as isopropyl, butyl, cetyl, 2-octyldodecyl myristate, hexyl stearate, butyl stearate, isobutyl stearate; dioctyl malate, hexyl laurate, 2-hexyldecyl laurate and isononyl isononanate, cetyl octanoate.
The composition can also comprise, as fatty ester, esters and di-esters of sugars of C6-C30, such as C12-C22 fatty acids. “Sugar” as used in the disclosure means oxygen-containing hydrocarbon compounds that possess several alcohol functions, with or without aldehyde or ketone functions, and having at least 4 carbon atoms. These sugars can be monosaccharides, oligosaccharides or polysaccharides.
As suitable sugars, non-limiting examples include sucrose, glucose, galactose, ribose, fucose, maltose, fructose, mannose, arabinose, xylose, lactose, and their derivatives, for example alkylated, such as methylated derivatives such as methylglucose.
The esters of sugars and of fatty acids can, for example, be chosen from the esters or mixtures of esters of sugars described previously and of linear or branched, saturated or unsaturated C6-C30, such as C12-C22 fatty acids. If they are unsaturated, these compounds can have one to three, conjugated or unconjugated, carbon-carbon double bonds.
The esters according to at least one embodiment can also be chosen from mono-, di-, tri- and tetra-esters, polyesters and mixtures thereof.
These esters can be for example oleate, laurate, palmitate, myristate, behenate, cocoate, stearate, linoleate, linolenate, caprate, arachidonates, or mixtures thereof such as the oleo-palmitate, oleo-stearate, palmito-stearate mixed esters.
For example, the mono- and di-esters can be used, and such as the mono- or di-oleate, stearate, behenate, oleopalmitate, linoleate, linolenate, oleostearate, of sucrose, of glucose or of methylglucose.
Non-limiting mention can be made of the product sold under the name GLUCATE® DO by the company Amerchol, which is a dioleate of methylglucose.
Exemplary esters or of mixtures of esters of sugar of fatty acid include: the products sold under the names F160, F140, F110, F90, F70, SL40 by the company Crodesta, denoting respectively the palmito-stearates of sucrose formed from 73% of monoester and 27% of di- and tri-ester, from 61% of monoester and 39% of di-, tri-, and tetra-ester, from 52% of monoester and 48% of di-, tri-, and tetra-ester, from 45% of monoester and 55% of di-, tri-, and tetra-ester, from 39% of monoester and 61% of di-, tri-, and tetra-ester, and the mono-laurate of sucrose; the products sold under the name Ryoto Sugar Esters for example with the reference B370 and corresponding to the behenate of sucrose formed from 20% of monoester and 80% of di-triester-polyester; sucrose mono-di-palmito-stearate marketed by the company Goldschmidt under the name TEGOSOFT® PSE.
Surfactants
In some embodiments, the hair color-altering compositions comprise at least one surfactant selected from anionic surfactants, nonionic surfactants and mixtures thereof.
The total amount of the one or more surfactants included in the hair color-altering compositions can vary, especially depending on the type of hair color-altering composition in with they are contained. The total amount of the one or more surfactants is typically about 0.1 to about 40 wt. %, based on the total weight of the hair color-altering composition, including all ranges and subranges therebetween. In some cases, the total amount of the one or more surfactants is about 0.1 to about 35 wt. %, about 0.1 to about 30 wt. %, about 0.1 to about 25 wt. %, about 0.1 to about 20 wt. %, about 0.1 to about 15 wt. %, about 0.1 to about 10 wt. %, about 0.1 to about 5 wt. %, about 0.5 to about 40 wt. %, about 0.5 to about 35 wt. %, about 0.5 to about 30 wt. %, about 0.5 to about 25 wt. %, about 0.5 to about 20 wt. %, about 0.5 to about 15 wt. %, about 0.5 to about 10 wt. %, about 0.5 to about 5 wt. %, about 1 wt. % to about 40 wt. %, about 1 wt. % to about 30 wt. %, about 1 wt. % to about 20 wt. %, about 1 wt. % to about 15 wt. %, about 1 wt. % to about 10 wt. %, or about 1 wt. % to about 5 wt. %.
Anionic Surfactants
The term “anionic surfactant” means a surfactant comprising, as ionic or ionizable groups, only anionic groups. These anionic groups are chosen preferably from the groups CO2H, CO2−, SO3H, SO3−, OSO3H, OSO3−O2PO2H, O2PO2H and O2PO22−.
The hair color-altering compositions may include one or more anionic surfactants. Non-limiting examples of anionic surfactants include alkyl sulfates, alkyl ether sulfates, acyl isethionates, acyl glycinates, acyl taurates, acyl amino acids, acyl sarcosinates, sulfosuccinates, sulfonates, and a mixture thereof, wherein the alkyl and acyl groups of all these compounds comprise from 6 to 24 carbon atoms. In some cases, anionic sulfate surfactants may be excluded from the one or more anionic surfactants. In such cases, the one or more anionic surfactants may be selected from the group consisting of acyl isethionates, acyl glycinates, acyl taurates, acyl amino acids, acyl sarcosinates, sulfosuccinates, sulfonates, and a mixture thereof, wherein the alkyl and acyl groups of all these compounds comprise from 6 to 24 carbon atoms. A more exhaustive list of anionic surfactants that may be included in the hair color-altering compositions is provided later, under the heading “Anionic Surfactants.”
The total amount of the one or more anionic surfactants may be about 1 to about 40 wt. %, based on the total weight of the hair color-altering composition, including all ranges and subranges therebetween. Furthermore, the total amount of the one or more anionic surfactants may be about 1 to about 35 wt. %, about 1 to about 30 wt. %, about 5 wt. % to about 40 wt. %, about 5 wt. % to about 25 wt. %, about 5 wt. % to about 30 wt. %, about 10 wt. % to about 40 wt. %, about 10 wt. % to about 35 wt. %, or about 15 wt. % to about 40 wt. %.
The anionic surfactant(s) that may be used may be alkyl sulfates, alkyl ether sulfates, alkylamido ether sulfates, alkylaryl polyether sulfates, monoglyceride sulfates, alkylsulfonates, alkylamide sulfonates, alkylarylsulfonates, alpha-olefin sulfonates, paraffin sulfonates, alkylsulfosuccinates, alkyl ether sulfosuccinates, alkylamide sulfosuccinates, alkyl sulfoacetates, acylsarcosinates, acylglutamates, alkylsulfosuccinamates, acylisethionates and N-acyltaurates, salts of alkyl monoesters and polyglycoside-polycarboxylic acids, acyllactylates, salts of D-galactoside uronic acids, salts of alkyl ether carboxylic acids, salts of alkyl aryl ether carboxylic acids, and salts of alkylamido ether carboxylic acids; or the non-salified forms of all of these compounds, the alkyl and acyl groups of all of these compounds containing from 6 to 24 carbon atoms and the aryl group denoting a phenyl group. Some of these compounds may be oxyethylenated and then preferably comprise from 1 to 50 ethylene oxide units.
The salts of C6-C24 alkyl monoesters of polyglycoside-polycarboxylic acids may be chosen from C6-C24 alkyl polyglycoside-citrates, C6-C24 alkyl polyglycoside-tartrates and C6-C24 alkyl polyglycoside-sulfo succinates.
When the anionic surfactant(s) are in salt form, they may be chosen especially from alkali metal salts such as the sodium or potassium salt and preferably the sodium salt, ammonium salts, amine salts and in particular amino alcohol salts, or alkaline-earth metal salts such as the magnesium salt.
Examples of amino alcohol salts that may especially be mentioned include monoethanolamine, diethanolamine and triethanolamine salts, monoisopropanolamine, diisopropanolamine or triisopropanolamine salts, 2-amino-2-methyl-1-propanol salts, 2-amino-2-methyl-1,3-propanediol salts and tris(hydroxymethyl)aminomethane salts. Alkali metal or alkaline-earth metal salts and in particular the sodium or magnesium salts may be used.
Use is also made of (C6-C24)alkyl sulfates, (C6-C24)alkyl ether sulfates, which are optionally ethoxylated, comprising from 2 to 50 ethylene oxide units, and a mixture thereof, in particular in the form of alkali metal salts or alkaline-earth metal salts, ammonium salts or amino alcohol salts. More preferentially, the anionic surfactant(s) are chosen from (C10-C20)alkyl ether sulfates, and in particular sodium lauryl ether sulfate.
Non-Ionic Surfactants
Non-ionic surfactants are compounds well known in themselves (see, e.g., in this regard, “Handbook of Surfactants” by M. R. Porter, Blackie & Son publishers (Glasgow and London), 1991, pp. 116-178), which is incorporated herein by reference in its entirety.
The total amount of the one or more non-ionic surfactants may be about 1 to about 40 wt. %, based on the total weight of the hair color-altering composition, including all ranges and subranges therebetween. Furthermore, the total amount of the one or more non-ionic surfactants may be about 1 to about 35 wt. %, about 1 to about 30 wt. %, about 5 wt. % to about 40 wt. %, about 5 wt. % to about 25 wt. %, about 5 wt. % to about 30 wt. %, about 10 wt. % to about 40 wt. %, about 10 wt. % to about 35 wt. %, or about 15 wt. % to about 40 wt. %.
The non-ionic surfactant can be, for example, selected from alcohols, alpha-diols, alkylphenols and esters of fatty acids, these compounds being ethoxylated, propoxylated or glycerolated and having at least one fatty chain comprising, for example, from 8 to 18 carbon atoms, it being possible for the number of ethylene oxide or propylene oxide groups to range from 2 to 50, and for the number of glycerol groups to range from 1 to 30. Maltose derivatives may also be mentioned. Non-limiting mention may also be made of copolymers of ethylene oxide and/or of propylene oxide; condensates of ethylene oxide and/or of propylene oxide with fatty alcohols; polyethoxylated fatty amides comprising, for example, from 2 to 30 mol of ethylene oxide; polyglycerolated fatty amides comprising, for example, from 1.5 to 5 glycerol groups, such as from 1.5 to 4; ethoxylated fatty acid esters of sorbitan comprising from 2 to 30 mol of ethylene oxide; ethoxylated oils from plant origin; fatty acid esters of sucrose; fatty acid esters of polyethylene glycol; polyethoxylated fatty acid mono or diesters of glycerol (C6-C24)alkylpolyglycosides; N—(C6-C24)alkylglucamine derivatives, amine oxides such as (C10-C14)alkylamine oxides or N—(C10-C14)acylaminopropylmorpholine oxides; and a mixture thereof.
The nonionic surfactants may preferably be chosen from polyoxyalkylenated or polyglycerolated nonionic surfactants. The oxyalkylene units are more particularly oxyethylene or oxypropylene units, or a mixture thereof, and are preferably oxyethylene units.
Examples of oxyalkylenated nonionic surfactants that may be mentioned include: [0115] oxyalkylenated (C8-C24)alkylphenols, saturated or unsaturated, linear or branched, oxyalkylenated C8-C30 alcohols, saturated or unsaturated, linear or branched, oxyalkylenated C8-C30 amides, esters of saturated or unsaturated, linear or branched, C8-C30 acids and of polyethylene glycols, polyoxyalkylenated esters of saturated or unsaturated, linear or branched, C8-C30 acids and of sorbitol, saturated or unsaturated, oxyalkylenated plant oils, condensates of ethylene oxide and/or of propylene oxide, inter alia, alone or as mixtures.
As examples of polyglycerolated nonionic surfactants, polyglycerolated C8-C40 alcohols are preferably used. In particular, the polyglycerolated C8-C40 alcohols correspond to the following formula:
RO—[CH2—CH(CH2OH)—O]m—H or RO—[CH(CH2OH)—CH2O]m—H
in which R represents a linear or branched C8-C40 and preferably C8-C30 alkyl or alkenyl radical, and m represents a number ranging from 1 to 30 and preferably from 1.5 to 10.
As examples of compounds that are suitable in the context of the invention, mention may be made of lauryl alcohol containing 4 mol of glycerol (INCI name: Polyglyceryl-4 Lauryl Ether), lauryl alcohol containing 1.5 mol of glycerol, oleyl alcohol containing 4 mol of glycerol (INCI name: Polyglyceryl-4 Oleyl Ether), oleyl alcohol containing 2 mol of glycerol (INCI name: Polyglyceryl-2 Oleyl Ether), cetearyl alcohol containing 2 mol of glycerol, cetearyl alcohol containing 6 mol of glycerol, oleocetyl alcohol containing 6 mol of glycerol, and octadecanol containing 6 mol of glycerol.
According to one of the embodiments according to the present invention, the nonionic surfactant may be selected from esters of polyols with fatty acids with a saturated or unsaturated chain containing for example from 8 to 24 carbon atoms, preferably 12 to 22 carbon atoms, and alkoxylated derivatives thereof, preferably with a number of alkyleneoxide of from 10 to 200, and more preferably from 10 to 100, such as glyceryl esters of a C8-C24, preferably C12-C22, fatty acid or acids and alkoxylated derivatives thereof, preferably with a number of alkyleneoxide of from 10 to 200, and more preferably from 10 to 100; polyethylene glycol esters of a C8-C24, preferably C12-C22, fatty acid or acids and alkoxylated derivatives thereof, preferably with a number of alkyleneoxide of from 10 to 200, and more preferably from 10 to 100; sorbitol esters of a C8-C24, preferably C12-C22, fatty acid or acids and alkoxylated derivatives thereof, preferably with a number of alkyleneoxide of from 10 to 200, and more preferably from 10 to 100; sugar (sucrose, glucose, alkylglycose) esters of a C8-C24, preferably C12-C22, fatty acid or acids and alkoxylated derivatives thereof, preferably with a number of alkyleneoxide of from 10 to 200, and more preferably from 10 to 100; ethers of fatty alcohols; ethers of sugar and a C8-C24, preferably C12-C22, fatty alcohol or alcohols; and a mixture thereof.
Preferably, the nonionic surfactant may be a nonionic surfactant with an HLB of 18.0 or less, such as from 4.0 to 18.0, more preferably from 6.0 to 15.0 and furthermore preferably from 9.0 to 13.0. The HLB is the ratio between the hydrophilic part and the lipophilic part in the molecule. This term HLB is well known to those skilled in the art and is described in “The HLB system. A time-saving guide to emulsifier selection” (published by ICI Americas Inc., 1984).
In some case, the nonionic surfactant is a fatty alkanolamide. Non-limiting examples of fatty alkanolamides that may be used include cocamide MEA, cocamide DEA, soyamide DEA, lauramide DEA, oleamide MIPA, stearamide MEA, myristamide DEA, stearamide DEA, oleylamide DEA, tallowamide DEA lauramide MIPA, tallowamide MEA, isostearamide DEA, isostearamide MEA, and a mixture thereof.
Cationic Polymer
In some instances, the hair color-altering compositions include one or more cationic polymers. Non-limiting examples of cationic polymers include poly(methacryloyloxyethyl trimethylammonium chloride), polyquaternium-37, quaternized cellulose derivatives, polyquaternium-4, polyquaternium-10, cationic alkyl polyglycosides, cationized honey, cationic guar derivatives, polymeric dimethyl diallyl ammonium salts and copolymers thereof with esters and amides of acrylic acid and methacrylic acid, copolymers of vinyl pyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, vinyl pyrrolidone-vinyl imidazolium methochloride copolymers, quaternized polyvinyl alcohol, polyquaternium-2, polyquaternium-7, polyquaternium-17, polyquaternium-18, polyquaternium-24, polyquaternium-27, and a mixture thereof. In some instances, the one or more cationic polymers may be selected from the group consisting of polyquaternium-4, polyquaternium-10, cationic guar derivatives, and a mixture thereof.
The cationic polymers can be a monoalkyl quaternary amine, such as stearyltrimonium chloride, soyatrimonium chloride or coco-ethyldimonium ethosulfate. Other suitable cationic polymers include, but are not limited to, behentrimonium chloride, dialkyl quaternary amines, such as dicetyldimonium chloride, dicocodimethyl ammonium chloride or distearyldimethyl ammonium chloride; and polyquaternium compounds, such as Polyquaternium-6, Polyquaternium-22 or Polyquaternium-5.
For example, cationic polymers may be chosen from polyquaterium-10 (also called quaternized polyhydroxyethyl cellulose), cetrimonium chloride (also called cetyl trimethyl ammonium chloride, CTAC), behentrimonium chloride (also known as docosyl trimethyl ammonium chloride), behentrimonium methosulfate, steartrimonium chloride, stearalkonium chloride, dicetyldimonium chloride, hydroxypropyltrimonium chloride, cocotrimonium methosulfate, olealkonium chloride, steartrimonium chloride, babassuamidopropalkonium chloride, brassicamidopropyl dimethylamine, Quaternium -91, Salcare/PQ-37, Quaternium-22, Quaternium-87, Polyquaternium-4, Polyquaternium-6, Polyquaternium-11, Polyquaternium-44, Polyquaternium-67, amodimethicone, lauryl betaine, Polyacrylate-1 Crosspolymer, steardimonium hydroxypropyl hydrolyzed wheat protein, behenamidopropyl PG-dimonium chloride, lauryldimonium hydroxypropyl hydrolyzed soy protein, aminopropyl dimethicone, Quaterium-8, and dilinoleamidopropyl dimethylamine dimethicone PEG-7 phosphate.
In some instances, the cationic polymers are cationic conditioning polymers. Examples of cationic conditioning polymers that can be used include, without limitation, cationic cellulose, cationic proteins, and cationic polymers. The cationic polymers can have a vinyl group backbone of amino and/or quaternary ammonium monomers. Cationic amino and quaternary ammonium monomers include, without limitation, dialkylamino alkylmethacrylate, monoalkylaminoalkyl acrylate, monoalkylaminoalkyl methacrylate, trialkyl methacryoloxyalkyl ammonium salt, trialkyl acryloxyalkyl ammonium salts, diallyl quaternary ammonium salts, vinyl compounds substituted with dialkyl aminoalkyl acrylate, and vinyl quaternary ammonium monomers having cyclic cationic nitrogen containing rings such as pyridinium, imidazolium, or quaternized pyrrolidine. Other examples of cationic conditioning polymers that can be used include, without limitation, hydroxypropyltrimonium honey, cocodimonium silk amino acids, cocodimonium hydroxypropyl hydrolyzed wheat or silk protein, polyquaternium-5, polyquaternium-11, polyquaternium-2, polyquaternium-4, polyquaternium-6, polyquaternium-7, polyquaternium-14, polyquaternium-16, polyquaternium-22, polyquaternium-10, and guar hydroxypropyltrimonium chloride.
In some cases quaternized polymeric cationic polymers are particularly useful. Particularly preferred are quaternary nitrogen polymers prepared by the polymerization of a dialkyldiallylammonium salt or copolymer thereof in which the alkyl group contains 1 to about 18 carbon atoms, and more preferably where the alkyl group is methyl or ethyl. Details concerning the preparation of these polymers can be found in U.S. Pat. Nos. 3,288,770, 3,412,019 and 4,772,462, incorporated herein by reference. For example, cationic homopolymers and copolymers of polydiallyldimethylammonium chloride are available in aqueous compositions sold under the trademark MERQUAT by the Calgon Corporation, subsidiary of Merck & Co., Pittsburgh, Pa. The homopolymer, which is named Polyquaternium-6 is sold under the trademark MERQUAT-100, and is described as having a weight average molecular weight of approximately 100,000. A copolymer reaction product of dimethyldiallylammonium chloride with acrylamide monomers is named Polyquaternium-7 is described as having a weight average molecular weight of approximately 500,000 and is sold under the trademark MERQUAT-550. Another copolymer reaction product of dimethyldiallylammonium chloride with acrylic acids having a weight average molecular weight from about 50,000 to about 10,000,000 has the name Polyquaternium-22 and is sold under the trademark MERQUAT-280. Polyquaternium-6 is particularly preferred.
Other polymeric conditioners include cationic copolymers of methylvinylimidazolium chloride and vinyl pyrrolidone, sold commercially by BASF Aktiengesellschaft, West Germany under the trademark LUVIQUAT at three comonomer ratios, namely at ratios of 95/5, 50/50 and 30/70 methylvinylimidazolium chloride to polyvinylpyrrolidone. These copolymers at all three comonomer ratios have the name Polyquaternium 16. Polymeric conditioners also include cationic cellulosic polymers of hydroxyethyl cellulose reacted with epichlorohydrin and quaternized with trimethylamine, sold under the trademark POLYMER JR in various viscosity grades and molecular sizes by Union Carbide Corporation, Danbury, Conn. These series of polymers are named Polyquaternium 10. Also useful are quaternized copolymers of hydroxyethylcellulose and dimethyldimethylammonium chloride, having the name Polyquaternium-4, sold in varying molecular weights under the trademark CELQUAT by National Starch and Chemical Corporation, Bridgewater, N.J.
The total amount of the one or more cationic polymers, when included in the hair color-altering composition, is typically about 0.01 to about 15 wt. %, based on the total weight of the composition, including all ranges and subranges therebetween. The total amount of the one or more cationic polymers may be about 0.01 to about 8 wt. %, about 0.01 to about 6 wt. %, about 0.01 to about 5 wt. %, about 0.05 to about 8 wt. %, about 0.05 to about 6 wt. %, about 0.05 to about 5 wt. %, about 0.1 to about 10 wt. %, about 0.1 to about 8 wt. %, about 0.1 to about 6 wt. %, or about 0.1 to about 5 wt.
Solvent
In one or more embodiments, the hair color-altering compositions described herein comprise a solvent. In some embodiments, the solvent comprises water. The total amount of water in the hair color-altering compositions may vary depending on the type of composition and the desired consistency, viscosity, etc. In some cases, the total amount of water is about 50 to 95 wt. %, based on the total weight of the hair color-altering composition, including all ranges and subranges therebetween. The total amount of water may be about 50 to about 90 wt. %, about 50 to about 85 wt. %, about 60 to 95 wt. %, about 60 to 90 wt. %, about 60 to about 85 wt. %, greater than 60 to about 95 wt. %, greater than 60 to about 90 wt. %, greater than 60 to about 85 wt. %, about 65 to about 95 wt. %, about 65 to about 90 wt. %, about 65 to about 85 wt. %, about 70 to about 95 wt. %, or about 70 to about 90 wt. %. In some instances, the total amount of water is greater than 60 wt. %. For example, the total amount of water may be at least 61, 62, 63, 64, 65, 66, 67, 68, 69, or 70 wt. % up to about 90 or about 95 wt. %. Likewise, the total amount of water may be at least 61, 62, 63, 64, 65, 66, 67, 68, 69, or 70 wt. % to about 95 wt. %, 61, 62, 63, 64, 65, 66, 67, 68, 69, or 70 wt. % to about 90 wt. %, or about 70 wt. % to about 90 wt. %.
In some embodiments, the composition may comprise other solvents, for example, glycerin, C1-4 alcohols, organic solvents, fatty alcohols, fatty ethers, fatty esters, polyols, glycols, vegetable oils, mineral oils, liposomes, laminar lipid materials, or any a mixture thereof. As examples of organic solvents, non-limiting mentions can be made of monoalcohols and polyols such as ethyl alcohol, isopropyl alcohol, propyl alcohol, benzyl alcohol, and phenylethyl alcohol, or glycols or glycol ethers such as, for example, monomethyl, monoethyl and monobutyl ethers of ethylene glycol, propylene glycol or ethers thereof such as, for example, monomethyl ether of propylene glycol, butylene glycol, hexylene glycol, dipropylene glycol as well as alkyl ethers of diethylene glycol, for example monoethyl ether or monobutyl ether of diethylene glycol. Other suitable examples of organic solvents are ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, propane diol, and glycerin. The organic solvents can be volatile or non-volatile compounds.
Further non-limiting examples of solvents which may be used include alkanediols (polyhydric alcohols) such as glycerin, 1,2,6-hexanetriol, trimethylolpropane, ethylene glycol, propylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, pentaethylene glycol, dipropylene glycol, 2-butene-1,4-diol, 2-ethyl-1,3-hexanediol, 2-methyl-2,4-pentanediol, (caprylyl glycol), 1,2-hexanediol, 1,2-pentanediol, and 4-methyl-1,2-pentanediol; alkyl alcohols having 1 to 4 carbon atoms such as ethanol, methanol, butanol, propanol, and isopropanol; glycol ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, ethylene glycol monomethyl ether acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol mono-n-propyl ether, ethylene glycol mono-iso-propyl ether, diethylene glycol mono-iso-propyl ether, ethylene glycol mono-n-butyl ether, ethylene glycol mono-t-butyl ether, diethylene glycol mono-t-butyl ether, 1-methyl-1-methoxybutanol, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol mono-t-butyl ether, propylene glycol mono-n-propyl ether, propylene glycol mono-iso-propyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol mono-n-propyl ether, and dipropylene glycol mono-iso-propyl ether; 2-pyrrolidone, N-methyl-2-pyrrolidone, 1,3-dimethyl-2-imidazolidinone, formamide, acetamide, dimethyl sulfoxide, sorbit, sorbitan, acetine, diacetine, triacetine, sulfolane, and a mixture thereof.
In some cases, the water-soluble solvent may be selected from the group consisting of one or more glycols, C1-4 alcohols, glycerin, and a mixture thereof. In some cases, the water-soluble solvent is selected from the group consisting of hexylene glycol, proplene glycol, caprylyl glycol, glycerin, isopropyl alcohol, and a mixture thereof.
Polyhydric alcohols are useful. Examples of polyhydric alcohols include glycerin, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, tripropylene glycol, 1,3-butanediol, 2,3-butanediol, 1,4-butanediol, 3-methyl-1,3-butanediol, 1,5-pentanediol, tetraethylene glycol, 1,6-hexanediol, 2-methyl-2,4-pentanediol, polyethylene glycol, 1,2,4-butanetriol, 1,2,6-hexanetriol, and a mixture thereof.
Polyol compounds may also be used. Non-limiting examples include the aliphatic diols, such as 2-ethyl-2-methyl-1,3-propanediol, 3,3-dimethyl-1,2-butanediol, 2,2-diethyl-1,3-propanediol, 2-methyl-2-propyl-1,3-propanediol, 2,4-dimethyl-2,4-pentanediol, 2,5-dimethyl-2,5-hexanediol, 5-hexene-1,2-diol, and 2-ethyl-1,3-hexanediol, and a mixture thereof.
The total amount of the water-soluble solvents (which is separate than the water in the compositions) may vary, but in some cases are about 0.01 to about 50 wt. %, based on the total weight of the composition. The total amount of the water-soluble solvents (separate from the water in the compositions), is about 0.01 to about 40 wt. %, about 0.01 to about 30 wt. %, about 0.01 to about 20 wt. %, about 0.01 to about 10 wt. %, about 0.01 to about 5 wt. %, 0.1 to about 40 wt. %, about 0.1 to about 30 wt. %, about 0.1 to about 20 wt. %, about 0.1 to about 10 wt. %, or about 0.1 to about 5 wt. %.
Thickening Agent
In some embodiments, the hair color-altering composition further comprises a thickening agent. In other embodiments, the hair color-altering composition does not comprise a thickening agent.
The hair color-altering compositions may contain one or more thickeners (also referred to as thickening agents or viscosity modifying agents). Classes of such agents include, but are not limited to, viscous liquids, such as polyethylene glycol, semisynthetic polymers, such as semisynthetic cellulose derivatives, synthetic polymers, such as carbomers, poloxamers, and acrylates/beheneth-25 methacrylate copolymer, acrylates copolymer, polyethyleneimines (e.g., PEI-10), naturally occurring polymers, such as acacia, tragacanth, alginates (e.g., sodium alginate), carrageenan, vegetable gums, such as xanthan gum, petroleum jelly, waxes, particulate associate colloids, such as bentonite, colloidal silicon dioxide, and microcrystalline cellulose, surfactants, such as PPG-2 hydroxyethyl coco/isostearamide, emulsifiers, such as disteareth-75 IPDI, and salts, such as sodium chloride, starches, such as hydroxypropyl starch phosphate, potato starch (modified or unmodified), celluloses such as hydroxyethylcellulose, guars such as hydroxypropyl guar, and a mixture thereof.
In some cases, the thickening agents may include one or more associative thickening polymers such as anionic associative polymers, amphoteric associative polymers, cationic associative polymers, nonionic associative polymers, and a mixture thereof. A non-limiting example of an amphoteric associative polymer is acrylates/beheneth-25methacrylate copolymer, sold under the tradename NOVETHIX L-10 (Lubrizol). Non-limiting examples of anionic associative polymers include INCI name: acrylates copolymer, sold under the tradename CARBOPOL Aqua SF-1 (Lubrizol), INCI name: acrylates crosspolymer-4, sold under the tradename CARBOPOL Aqua SF-2 (Lubrizol), and a mixture thereof. The associative thickening polymers, for instance, the acrylates copolymer and/or the acrylates crosspolymer-4, may be neutralized in water or an aqueous solution with a neutralizing agent before the polymer is added into a hair color-altering composition.
In some embodiments, the thickener is chosen from hydroxyethylcellulose, cetyl hydroxyethylcellulose, and combinations thereof.
The total amount of the one or more thickening agents may vary, but in some cases is about 0.1 to about 15 wt. %, about 0.1 to about 10 wt. %, about 0.1 to about 8 wt. %, about 0.1 to about 6 wt. %, about 0.1 to about 5 wt. %, about 0.5 to about 10 wt. %, about 0.5 to about 8 wt. %, about 0.5 to about wt. %, about 0.5 to about 5 wt. %, about 1 to about 10 wt. %, about 1 to about 8 wt. %, about 1 to about 6 wt. %, or about 1 to about 5 wt. %, based on the total weight of the composition.
Optional Components
The composition according to the disclosure can comprise any auxiliary or additional component suitable for use in cosmetic compositions, and in particular suitable for hair coloring or lightening compositions. Such components may include, but are not limited to, cosmetically acceptable solvents, silicone compounds, rheology modifying agents such as acrylic polymers, cationic, nonionic, amphoteric or zwitterionic surfactants or mixtures thereof, anionic, cationic, nonionic, amphoteric or zwitterionic polymers or mixtures, film forming agents or polymers, humectants and moisturizing agents, fatty substances other than the claimed fatty substances, emulsifying agents other than fatty substances, fillers, structuring agents, propellants, shine agents, conditioning agents, antioxidants or reducing agents, penetrants, sequestrants, fragrances, buffers, dispersants, conditioning agents, for instance volatile or non-volatile, modified or unmodified silicones, ceramides, preserving agents, opacifiers, sunscreen agents, and antistatic agents. Acids, for example citric acid, can affect the pH of the system resulting in loss of lift. As such, optional auxiliary or additional components will be chosen so as to minimize any detrimental effect to the advantages of the hair color bases and compositions described herein.
Exemplary auxiliary ingredients useful in the hair color composition according to various embodiments of the disclosure include, but are not limited to, rheology-modifying agents, bleach activators and co-bleach activators, direct dyes, chelants, fatty substances, ceramides, alkoxyaminosilicones, silanes, and lift-enhancing agents, such as nitrogen-containing compounds and metal catalyst compounds.
The composition may also contain acid and alkali pH adjusters, which are well known in the art in the cosmetic treatment of keratin fibers, such as hair. Such pH adjusters include, but are not limited to, sodium metasilicate, silicate compounds, citric acid, ascorbic acid, and carbonate compounds.
The pH adjusters may, in various embodiments, be present in the hair color composition in an amount effective with a pH of greater than 7.
The hair color-altering compositions of the instant disclosure may be free or essentially free of taurate surfactants and salts thereof. For example, the compositions may be free or essentially free of taurate surfactants and salts thereof, of the following formula:
R1CO—NR2—CH2CH2SO3M,
wherein R1 denotes a saturated or unsaturated hydrocarbon group with an average number of carbon atoms of 7-19; R2 denotes hydrogen or an alkyl group with an average number of carbon atoms of 1-3; and M denotes an alkali metal, alkali earth metal, ammonium, or organic amine or derivative. Specific examples include N-methyl cocoyl taurate and sodium cocoyl taurate.
The compositions of the disclosure may be free or essentially free of polyethylene glycol (PEG) and/or derivatives thereof and may be free or essentially free of propylene glycol (PPG) and/or derivatives thereof. For example, the compositions may be free or essentially free of polyethylene glycols having a molecular weight of 200-10,000, or polyethylene glycols having a molecular weight of 200-1,000. Furthermore, PEGylated surfactants may also be excluded from the hair color-altering compositions. Non-limiting examples of PEGylated surfactants include ethoxylated fatty esters.
Kits
Another aspect of the invention pertains to kits which comprise any of the hair color-altering agents described herein. In some embodiments, the kit further comprises a developer composition. The developer composition may be housed in a separate container from the hair color-altering composition, and may then be mixed prior to application onto hair.
In some embodiments, the developer composition is aqueous or is in the form of an emulsion. The developer composition can contain at least one solvent, chosen from water, organic solvents, and mixtures thereof.
In alternative embodiments, the developer composition is substantially anhydrous. The term “substantially anhydrous” means that the developer composition is either completely free of water or contains no appreciable amount of water, for example, no more than 5% by weight, or no more than 2% by weight, or no more than 1% by weight, based on the weight of the developer composition. It should be noted that this refers for example to bound water, such as the water of crystallization of the salts or traces of water absorbed by the raw materials used in the preparation of the compositions according to embodiments of the disclosure.
When the developer composition is substantially anhydrous, the developer composition may comprise at least one solvent chosen from organic solvents. Suitable organic solvents for use in the developer composition include ethanol, isopropyl alcohol, propanol, benzyl alcohol, phenyl ethyl alcohol, glycols and glycol ethers, such as propylene glycol, hexylene glycol, ethylene glycol monomethyl, monoethyl or monobutyl ether, propylene glycol and its ethers, such as propylene glycol monomethyl ether, butylene glycol, dipropylene glycol, diethylene glycol alkyl ethers, such as diethylene glycol monoethyl ether and monobutyl ether, ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, propane diol, glycerin, hydrocarbons such as straight chain hydrocarbons, mineral oil, polybutene, hydrogenated polyisobutene, hydrogenated polydecene, polydecene, squalane, petrolatum, isoparaffins, and mixtures, thereof.
The organic solvents for use in the present invention can be volatile or non-volatile compounds. The organic solvent may, for example, be present in an amount ranging from about 0.5% to about 70% by weight, such as from about 2% to about 60% by weight, preferably from about 5 to about 50% by weight, relative to the total weight of the developer composition or system in which it is present.
The developer composition may be in the form of a powder, gel, liquid, foam, lotion, cream, mousse, and emulsion.
The pH of the developer composition can range from about 2 to about 12, such as from about 6 to about 11, and it may be adjusted to the desired value using acidifying/alkalizing agents that are well known in the art. In certain embodiments, the pH of the developer composition is below 7. The pH of the composition resulting from mixing together the hair color-altering composition and the developer composition may range from about 7, 8, 9, 10 or 11 to about 8, 9, 10, 11 or 12.
According to at least one embodiment, the system and/or compositions comprising the system and the developer composition are free or substantially free of ammonia.
Methods
Another aspect of the invention pertains to methods of using any of the compositions described herein. In one or more embodiments, the method comprises applying the hair color-altering composition to hair. The composition may be left on the hair for a period of time sufficient to achieve the desired alteration in hair tone. For example, the hair color composition may be left on the hair for up to one hour, such as from about 3 minutes to about 45 minutes, from about 5 minutes to about 30 minutes, or from about 10 minutes to about 20 minutes. In further embodiments, the hair color composition may be left on the hair for a period up to about 30 minutes, such as, for example, from about 1 to about 30 minutes, about 1 to about 10 minutes, or about 1 to about 5 minutes. One skilled in the art will, by considering various factors such as the starting and desired tones of the hair, be able to determine an appropriate amount of time to leave the hair color composition on the hair in order to achieve the desired alternation in hair tone. By way of non-limiting example, various embodiments according to the disclosure may provide for an increase of 1 to 4 in the tone height of the hair. In some embodiments, the hair color-altering composition is mixed with a developer composition prior to application to hair. If desired, the composition may, optionally, be shampooed and/or rinsed off the hair.
Implementation of the present disclosure is provided by way of the following examples. The examples serve to illustrate the technology without being limiting in nature.
Three formulas were prepared with the ingredients shown below in Table 1. Comparative Example 1 is comparative for at least the reason it does not contain citric acid. Examples 2 and 3 are inventive. The three formulas were in the form of a cream.
Thermo-rheology measurements were taken of the three formulas, and the evolution of elastic modulus (G′) measured as a function of time and temperature. These plots are shown in
Compositions B-F were prepared and their performance compared with a commercial benchmark product. Hair tresses of highly bleached Caucasian hair (1 g/27 cm) of approximately fifty hair fibers were treated three times as outlined below, and then subjected to testing using a Miniature Tensile Tester (MTT). The commercial benchmark product and each of Compositions B-F were mixed with 40V developer composition in a ratio of 1:2 (Benchmark/Compositions B-F: Developer Composition). 8 grams of the commercial benchmark product or Composition B-F was mixed with 16 grams of 40V developer composition and each of the mixtures were used to treat two hair tresses. The mixtures were applied to the hair tresses and allowed to process for 50 minutes. After 50 minutes of processing, the hair tresses were rinsed and then shampooed three times. After being shampooed three times, the hair tresses were blow dried. The process was repeated two more times, i.e., the entire hair coloring process was carried out for a total of three times. The tresses were then subjected to break stress testing and to elastic modulus testing.
The break stress represents the force/area needed to break the hair fiber. A higher break stress represents a stronger and stiffer hair fiber. The hair tresses treated as set forth above were subjected to break stress testing. The results are provided in the table below, and graphically presented in
Treatment with Composition E resulted in a statistically higher break stress compared to the commercial benchmark product. Treatment with Compositions B, C, D, and F resulted in a break stress that was similar to treatment with the commercial benchmark product. There was no statistical difference in break stress for hair tresses treated with Compositions B, C, D, and F compared to hair tresses treated with the commercial benchmark product.
The Young's modulus represents a measure of the hair's spring-like structure (elasticity). The mean Young's modulus for the hair tresses treated as set forth above was determined. The results are provided in the table below and graphically presented in
Treatment with Compositions B-F resulted in an elastic modulus that was similar to treatment with the commercial benchmark product. There was no statistical difference in elastic modulus for hair tresses treated with Compositions B-F compared to hair tresses treated with the commercial benchmark product.
As used herein, the terms “comprising,” “having,” and “including” (or “comprise,” “have,” and “include”) are used in their open, non-limiting sense.
The terms “a,” “an,” and “the” are understood to encompass the plural as well as the singular.
Thus, the term “a mixture thereof” also relates to “mixtures thereof.” Throughout the disclosure, the the term “a mixture thereof” is used, following a list of elements as shown in the following example where letters A-F represent the elements: “one or more elements selected from the group consisting of A, B, C, D, E, F, and a mixture thereof.” The term, “a mixture thereof” does not require that the mixture include all of A, B, C, D, E, and F (although all of A, B, C, D, E, and F may be included). Rather, it indicates that a mixture of any two or more of A, B, C, D, E, and F can be included. In other words, it is equivalent to the phrase “one or more elements selected from the group consisting of A, B, C, D, E, F, and a mixture of any two or more of A, B, C, D, E, and F.”
Likewise, the term “a salt thereof” also relates to “salts thereof.” Thus, where the disclosure refers to “an element selected from the group consisting of A, B, C, D, E, F, a salt thereof, and a mixture thereof,” it indicates that that one or more of A, B, C, D, and F may be included, one or more of a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be include, or a mixture of any two of A, B, C, D, E, F, a salt of A, a salt of B, a salt of C, a salt of D, a salt of E, and a salt of F may be included.
The salts, for example, the salts of the amino acids, the amino sulfonic acids, and the non-polymeric mono, di, and/or tricarboxylic acids, which are referred to throughout the disclosure may include salts having a counter-ion such as an alkali metal, alkaline earth metal, or ammonium counterion. This list of counterions, however, is non-limiting.
The expression “one or more” means “at least one” and thus includes individual components as well as mixtures/combinations.
Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients and/or reaction conditions are to be understood as being modified in all instances by the term “about,” meaning within +/−5% of the indicated number.
All percentages, parts and ratios herein are based upon the total weight of the compositions of the present invention, unless otherwise indicated.
“Keratinous substrates” as used herein, includes, but is not limited to keratin fibers such as hair and/or scalp on the human head.
“Conditioning” as used herein means imparting to one or more hair fibers at least one property chosen from combability, moisture-retentivity, luster, shine, and softness. The state of conditioning can be evaluated by any means known in the art, such as, for example, measuring, and comparing, the ease of combability of the treated hair and of the untreated hair in terms of combing work (gm-in), and consumer perception.
The term “treat” (and its grammatical variations) as used herein refers to the application of the compositions of the present disclosure onto the surface of keratinous substrates such as hair. The term ‘treat” (and its grammatical variations) as used herein also refers to contacting keratinous substrates such as hair with the compositions of the present disclosure.
A “rinse-off” product refers to a composition such as a hair color-altering composition that is rinsed and/or washed with water either after or during the application of the composition onto the keratinous substrate, and before drying and/or styling said keratinous substrate. At least a portion, and typically most, of the composition is removed from the keratinous substrate during the rinsing and/or washing.
The term “stable” as used herein means that the composition does not exhibit phase separation and/or crystallization for a period of time, for example, for at least 1 day (24 hours), one week, one month, or one year.
“Volatile”, as used herein, means having a flash point of less than about 100° C.
“Non-volatile”, as used herein, means having a flash point of greater than about 100° C.
As used herein, all ranges provided are meant to include every specific range within, and combination of sub ranges between, the given ranges. Thus, a range from 1-5, includes specifically 1, 2, 3, 4 and 5, as well as sub ranges such as 2-5, 3-5, 2-3, 2-4, 1-4, etc.
The term “substantially free” or “essentially free” as used herein means that there is less than about 5% by weight of a specific material added to a composition, based on the total weight of the compositions. Nonetheless, the compositions may include less than about 3 wt. %, less than about 2 wt. %, less than about 1 wt. %, less than about 0.5 wt. %, less than about 0.1 wt. %, or none of the specified material.
All ranges and values disclosed herein are inclusive and combinable. For examples, any value or point described herein that falls within a range described herein can serve as a minimum or maximum value to derive a sub-range, etc.
All publications and patent applications cited in this specification are herein incorporated by reference, and for any and all purposes, as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. In the event of an inconsistency between the present disclosure and any publications or patent application incorporated herein by reference, the present disclosure controls.
This application claims priority to U.S. Provisional Patent Application No. 62/611,865, filed on Dec. 29, 2017, entitled “COMPOSITIONS FOR ALTERING THE COLOR OF HAIR,” the entirety of which is herein incorporated by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2261002 | Ritter | Oct 1941 | A |
| 2271378 | Searle | Jan 1942 | A |
| 2273780 | Dittmar | Feb 1942 | A |
| 2375853 | Kirby et al. | May 1945 | A |
| 2388614 | Kirby et al. | Nov 1945 | A |
| 2454547 | Bock et al. | Nov 1948 | A |
| 2674580 | Henkin | Apr 1954 | A |
| 2850351 | Moore et al. | Sep 1958 | A |
| 2961347 | Floyd | Nov 1960 | A |
| 3142623 | Zviak et al. | Jul 1964 | A |
| 3193464 | Edman et al. | Jul 1965 | A |
| 3206462 | McCarty | Sep 1965 | A |
| 3227615 | Korden | Jan 1966 | A |
| 3288770 | Butler | Nov 1966 | A |
| 3412019 | Hoover et al. | Nov 1968 | A |
| 3472243 | Wall et al. | Oct 1969 | A |
| 3472840 | Stone et al. | Oct 1969 | A |
| 3589978 | Kamal et al. | Jun 1971 | A |
| 3632559 | Matter et al. | Jan 1972 | A |
| 3766267 | Zak et al. | Oct 1973 | A |
| 3840656 | Kalopissis et al. | Oct 1974 | A |
| 3874870 | Green et al. | Apr 1975 | A |
| 3917817 | Vanlerberghe et al. | Nov 1975 | A |
| 3929990 | Green et al. | Dec 1975 | A |
| 3966904 | Green et al. | Jun 1976 | A |
| 4001432 | Green et al. | Jan 1977 | A |
| 4003699 | Rose et al. | Jan 1977 | A |
| 4005193 | Green et al. | Jan 1977 | A |
| 4012398 | Conner et al. | Mar 1977 | A |
| 4013787 | Vanlerberghe et al. | Mar 1977 | A |
| 4025617 | Green et al. | May 1977 | A |
| 4025627 | Green et al. | May 1977 | A |
| 4025653 | Green et al. | May 1977 | A |
| 4026945 | Green et al. | May 1977 | A |
| 4027020 | Green et al. | May 1977 | A |
| 4031307 | DeMartino et al. | Jun 1977 | A |
| 4075136 | Schaper | Feb 1978 | A |
| 4131576 | Iovine et al. | Dec 1978 | A |
| 4166894 | Schaper | Sep 1979 | A |
| 4172887 | Vanlerberghe et al. | Oct 1979 | A |
| RE30199 | Rose et al. | Jan 1980 | E |
| 4189468 | Vanlerberghe et al. | Feb 1980 | A |
| 4197865 | Jacquet et al. | Apr 1980 | A |
| 4217914 | Jacquet et al. | Aug 1980 | A |
| 4240450 | Grollier et al. | Dec 1980 | A |
| 4277581 | Vanlerberghe et al. | Jul 1981 | A |
| 4348202 | Grollier et al. | Sep 1982 | A |
| 4349532 | Vanlerberghe et al. | Sep 1982 | A |
| 4381919 | Jacquet et al. | May 1983 | A |
| 4412943 | Hirota et al. | Nov 1983 | A |
| 4422853 | Jacquet et al. | Dec 1983 | A |
| 4425132 | Grollier et al. | Jan 1984 | A |
| 4532950 | Lang et al. | Aug 1985 | A |
| 4579732 | Grollier et al. | Apr 1986 | A |
| 4591610 | Grollier | May 1986 | A |
| 4608250 | Jacquet et al. | Aug 1986 | A |
| 4734277 | Login | Mar 1988 | A |
| 4761273 | Grollier et al. | Aug 1988 | A |
| 4770873 | Wolfram et al. | Sep 1988 | A |
| 4772462 | Boothe et al. | Sep 1988 | A |
| 4777040 | Grollier et al. | Oct 1988 | A |
| 4793992 | Mathews et al. | Dec 1988 | A |
| 4793993 | Siuta-Mangano et al. | Dec 1988 | A |
| 4812307 | Siuta-Mangano | Mar 1989 | A |
| 4834971 | Klenk et al. | May 1989 | A |
| 4855130 | Konrad et al. | Aug 1989 | A |
| 4906460 | Kim et al. | Mar 1990 | A |
| 4948579 | Jacquet et al. | Aug 1990 | A |
| 4970066 | Grollier et al. | Nov 1990 | A |
| 5061289 | Clausen et al. | Oct 1991 | A |
| 5085860 | Junino et al. | Feb 1992 | A |
| 5091171 | Yu et al. | Feb 1992 | A |
| 5143518 | Madrange et al. | Sep 1992 | A |
| 5196189 | Jacquet et al. | Mar 1993 | A |
| 5221286 | Singleton et al. | Jun 1993 | A |
| 5293885 | Darkwa et al. | Mar 1994 | A |
| 5350572 | Savaides et al. | Sep 1994 | A |
| 5356438 | Kim et al. | Oct 1994 | A |
| 5380340 | Neunhoeffer et al. | Jan 1995 | A |
| 5534267 | Neunhoeffer et al. | Jul 1996 | A |
| 5565216 | Cowsar et al. | Oct 1996 | A |
| 5593662 | Deckner | Jan 1997 | A |
| 5616150 | Moeller et al. | Apr 1997 | A |
| 5628991 | Samain et al. | May 1997 | A |
| 5635168 | Burns et al. | Jun 1997 | A |
| 5651960 | Chan et al. | Jul 1997 | A |
| 5656265 | Bailey et al. | Aug 1997 | A |
| 5663366 | Neunhoeffer et al. | Sep 1997 | A |
| 5688291 | Said et al. | Nov 1997 | A |
| 5708151 | Möckli | Jan 1998 | A |
| 5750099 | Yoshihara et al. | May 1998 | A |
| 5766576 | Löwe et al. | Jun 1998 | A |
| 5785962 | Hinz et al. | Jul 1998 | A |
| 5811085 | Halloran | Sep 1998 | A |
| 5833966 | Samain | Nov 1998 | A |
| 5853707 | Wells et al. | Dec 1998 | A |
| 5869068 | De Lacharriere et al. | Feb 1999 | A |
| 5951969 | Golinski et al. | Sep 1999 | A |
| 5972322 | Rath | Oct 1999 | A |
| 5985803 | Rizvi et al. | Nov 1999 | A |
| 6013250 | Cannell et al. | Jan 2000 | A |
| 6015574 | Cannell et al. | Jan 2000 | A |
| 6036966 | Youssefyeh | Mar 2000 | A |
| 6090762 | Clapperton et al. | Jul 2000 | A |
| 6099592 | Vidal et al. | Aug 2000 | A |
| 6173717 | Schonert et al. | Jan 2001 | B1 |
| 6231843 | Hoelzel et al. | May 2001 | B1 |
| 6241971 | Fox | Jun 2001 | B1 |
| 6284003 | Rose et al. | Sep 2001 | B1 |
| 6309426 | Dias et al. | Oct 2001 | B1 |
| 6338741 | Vidal et al. | Jan 2002 | B1 |
| 6348189 | Tanabe et al. | Feb 2002 | B1 |
| 6348200 | Nakajima et al. | Feb 2002 | B1 |
| 6358502 | Tanabe et al. | Mar 2002 | B1 |
| 6398821 | Dias et al. | Jun 2002 | B1 |
| 6458906 | Torgerson et al. | Oct 2002 | B1 |
| 6488945 | Sato | Dec 2002 | B2 |
| 6515050 | Mitsuzuka et al. | Feb 2003 | B1 |
| 6537532 | Torgerson et al. | Mar 2003 | B1 |
| 6544500 | O'Toole et al. | Apr 2003 | B1 |
| 6562327 | Nguyen et al. | May 2003 | B1 |
| 6569412 | Yamaguchi et al. | May 2003 | B2 |
| 6645258 | Vidal et al. | Nov 2003 | B2 |
| 6645478 | Rollat et al. | Nov 2003 | B2 |
| 6669933 | Duffer | Dec 2003 | B2 |
| 6706258 | Gallagher et al. | Mar 2004 | B1 |
| 6730789 | Birault et al. | May 2004 | B1 |
| 6767875 | Snyder et al. | Jul 2004 | B1 |
| 6979439 | Sakai et al. | Dec 2005 | B1 |
| 6984250 | Legrand et al. | Jan 2006 | B1 |
| 7041142 | Chan et al. | May 2006 | B2 |
| 7044986 | Ogawa et al. | May 2006 | B2 |
| 7135167 | Legrand et al. | Nov 2006 | B2 |
| 7147843 | Yoshida et al. | Dec 2006 | B2 |
| 7151079 | Fack et al. | Dec 2006 | B2 |
| 7204861 | Marsh et al. | Apr 2007 | B2 |
| 7390479 | Sockel et al. | Jun 2008 | B2 |
| 7427656 | Decarolis et al. | Sep 2008 | B2 |
| 7495037 | Moszner et al. | Feb 2009 | B2 |
| 7598213 | Geary et al. | Oct 2009 | B2 |
| 7612141 | Sakai et al. | Nov 2009 | B2 |
| 7815901 | Mathonneau et al. | Oct 2010 | B2 |
| 7905926 | DeGeorge et al. | Mar 2011 | B2 |
| 7915208 | Roso et al. | Mar 2011 | B2 |
| 7931698 | Simonet et al. | Apr 2011 | B2 |
| 7972388 | Hamilton et al. | Jul 2011 | B2 |
| 7981405 | Ueyama et al. | Jul 2011 | B2 |
| 8163861 | Puerta et al. | Apr 2012 | B2 |
| 8288329 | Hata | Oct 2012 | B2 |
| 8298519 | Adams et al. | Oct 2012 | B2 |
| 8357356 | Zaeska | Jan 2013 | B2 |
| 8388701 | Uellner et al. | Mar 2013 | B2 |
| 8513200 | Dixon et al. | Aug 2013 | B2 |
| 8613913 | Chang et al. | Dec 2013 | B2 |
| 8632758 | Terada | Jan 2014 | B2 |
| 8642021 | Brautigam et al. | Feb 2014 | B2 |
| 8642659 | Springer et al. | Feb 2014 | B2 |
| 8921292 | Fujita et al. | Dec 2014 | B2 |
| 9006162 | Rizk | Apr 2015 | B1 |
| 9044409 | Carola et al. | Jun 2015 | B2 |
| 9095518 | Pressly et al. | Aug 2015 | B2 |
| 9144537 | Pressly et al. | Sep 2015 | B1 |
| 9175114 | Puerta et al. | Nov 2015 | B2 |
| 9180086 | Cabourg et al. | Nov 2015 | B2 |
| 9283156 | Savaides et al. | Mar 2016 | B2 |
| 9326926 | Pressly et al. | May 2016 | B2 |
| 9402796 | Briggs et al. | Aug 2016 | B2 |
| 9498419 | Pressly et al. | Nov 2016 | B2 |
| 9597273 | Pressly et al. | Mar 2017 | B2 |
| 9610241 | Cabourg et al. | Apr 2017 | B2 |
| 9849071 | Fack et al. | Dec 2017 | B2 |
| 9918923 | Naiberk et al. | Mar 2018 | B1 |
| 9993406 | Manneck et al. | Jun 2018 | B2 |
| 10004673 | Elsen-Wahrer et al. | Jun 2018 | B1 |
| 10085931 | Baghdadli et al. | Oct 2018 | B2 |
| 10219994 | Lechner et al. | Mar 2019 | B2 |
| 10231915 | Dreher et al. | Mar 2019 | B2 |
| 10561599 | Patterson et al. | Feb 2020 | B2 |
| 10576307 | Patterson et al. | Mar 2020 | B2 |
| 20010029637 | Nakashimada et al. | Oct 2001 | A1 |
| 20010042276 | Kawasoe et al. | Nov 2001 | A1 |
| 20010052354 | Nishibe et al. | Dec 2001 | A1 |
| 20020029429 | Dias et al. | Mar 2002 | A1 |
| 20020032933 | Dias et al. | Mar 2002 | A1 |
| 20020053110 | Dias et al. | May 2002 | A1 |
| 20020155081 | Coope | Oct 2002 | A1 |
| 20020189034 | Kitabata et al. | Dec 2002 | A1 |
| 20030012761 | Koshida et al. | Jan 2003 | A1 |
| 20030019051 | Vidal et al. | Jan 2003 | A9 |
| 20030049222 | Akhter et al. | Mar 2003 | A1 |
| 20030072962 | Matsuzaki et al. | Apr 2003 | A1 |
| 20030074743 | Noguchi et al. | Apr 2003 | A1 |
| 20030083380 | Yu et al. | May 2003 | A1 |
| 20030152543 | Legrand et al. | Aug 2003 | A1 |
| 20030215415 | Mitsumatsu et al. | Nov 2003 | A1 |
| 20040034944 | Legrand et al. | Feb 2004 | A1 |
| 20040034946 | Legrand et al. | Feb 2004 | A1 |
| 20040067212 | Tokuyama et al. | Apr 2004 | A1 |
| 20040086475 | Boswell et al. | May 2004 | A1 |
| 20040088800 | Cotteret | May 2004 | A1 |
| 20040156877 | Tokuyama et al. | Aug 2004 | A1 |
| 20040181883 | Legrand et al. | Sep 2004 | A1 |
| 20040202689 | Subramanyan et al. | Oct 2004 | A1 |
| 20040216244 | Cotteret et al. | Nov 2004 | A1 |
| 20040228580 | Lee et al. | Nov 2004 | A1 |
| 20040241114 | Gupta | Dec 2004 | A1 |
| 20040256598 | Pios | Dec 2004 | A1 |
| 20040258652 | Pascaly et al. | Dec 2004 | A1 |
| 20050036970 | Sabbagh et al. | Feb 2005 | A1 |
| 20050050013 | Ferlitsch | Mar 2005 | A1 |
| 20050087718 | Okada | Apr 2005 | A1 |
| 20050095215 | Popp | May 2005 | A1 |
| 20050176615 | Kinoshita et al. | Aug 2005 | A1 |
| 20050186164 | Akyuz | Aug 2005 | A1 |
| 20050191263 | Ueyama et al. | Sep 2005 | A1 |
| 20050193501 | Chan et al. | Sep 2005 | A1 |
| 20050201966 | Ueyama et al. | Sep 2005 | A1 |
| 20060024257 | Chang et al. | Feb 2006 | A1 |
| 20060045862 | Tada et al. | Mar 2006 | A1 |
| 20060062751 | Sato et al. | Mar 2006 | A1 |
| 20060075580 | Chan et al. | Apr 2006 | A1 |
| 20060093571 | Glinski | May 2006 | A1 |
| 20060135397 | Bissey-Beugras et al. | Jun 2006 | A1 |
| 20060166845 | Terada | Jul 2006 | A1 |
| 20060182702 | Lazzeri et al. | Aug 2006 | A1 |
| 20060198807 | Morioka | Sep 2006 | A1 |
| 20060228316 | Cannell et al. | Oct 2006 | A1 |
| 20060251673 | Hwang et al. | Nov 2006 | A1 |
| 20060276369 | Levecke et al. | Dec 2006 | A1 |
| 20070041921 | Neill et al. | Feb 2007 | A1 |
| 20070067924 | Beck et al. | Mar 2007 | A1 |
| 20070107142 | Nguyen et al. | May 2007 | A1 |
| 20070116661 | Mata | May 2007 | A1 |
| 20070160560 | Laurent et al. | Jul 2007 | A1 |
| 20070161543 | Yu et al. | Jul 2007 | A1 |
| 20070190008 | Campain et al. | Aug 2007 | A1 |
| 20070261594 | Vaskelis et al. | Nov 2007 | A1 |
| 20070264208 | Mougin et al. | Nov 2007 | A1 |
| 20080025937 | Cassier | Jan 2008 | A1 |
| 20080025939 | Cassier et al. | Jan 2008 | A1 |
| 20080066773 | Anderson et al. | Mar 2008 | A1 |
| 20080118458 | Giesen | May 2008 | A1 |
| 20080124295 | Duranton et al. | May 2008 | A1 |
| 20080138309 | Malle et al. | Jun 2008 | A1 |
| 20080141468 | Cotteret | Jun 2008 | A1 |
| 20080187506 | Carballada et al. | Aug 2008 | A1 |
| 20080226576 | Benabdillah et al. | Sep 2008 | A1 |
| 20080233072 | Bureiko et al. | Sep 2008 | A1 |
| 20080306025 | Yu et al. | Dec 2008 | A1 |
| 20090022681 | Carballada et al. | Jan 2009 | A1 |
| 20090041699 | Molenda et al. | Feb 2009 | A1 |
| 20090041701 | Taylor | Feb 2009 | A1 |
| 20090041713 | Taylor | Feb 2009 | A1 |
| 20090053165 | Brown et al. | Feb 2009 | A1 |
| 20090071493 | Nguyen et al. | Mar 2009 | A1 |
| 20090074683 | Nguyen et al. | Mar 2009 | A1 |
| 20090126756 | Syed et al. | May 2009 | A1 |
| 20090208499 | Yu et al. | Aug 2009 | A1 |
| 20090214628 | de Rijk | Aug 2009 | A1 |
| 20090252697 | Barbarat et al. | Oct 2009 | A1 |
| 20090274677 | Isaacs et al. | Nov 2009 | A1 |
| 20100004391 | Haddleton et al. | Jan 2010 | A1 |
| 20100015079 | Schrader | Jan 2010 | A1 |
| 20100081716 | Matsunaga et al. | Apr 2010 | A1 |
| 20100119468 | Garcia Castro et al. | May 2010 | A1 |
| 20100154140 | Simonet et al. | Jun 2010 | A1 |
| 20100158845 | Ellington et al. | Jun 2010 | A1 |
| 20100158964 | Cunningham et al. | Jun 2010 | A1 |
| 20100178267 | Puerta et al. | Jul 2010 | A1 |
| 20100189795 | Dreher | Jul 2010 | A1 |
| 20100202998 | Ramos-Stanbury et al. | Aug 2010 | A1 |
| 20100247463 | Yu et al. | Sep 2010 | A1 |
| 20100303748 | Hercouet | Dec 2010 | A1 |
| 20110056508 | Gross et al. | Mar 2011 | A1 |
| 20110061671 | Neplaz et al. | Mar 2011 | A1 |
| 20110142778 | Hloucha et al. | Jun 2011 | A1 |
| 20110150804 | Nojiri et al. | Jun 2011 | A1 |
| 20110213033 | Tokuyama et al. | Sep 2011 | A1 |
| 20110256084 | Dixon et al. | Oct 2011 | A1 |
| 20110311463 | Diamond et al. | Dec 2011 | A1 |
| 20120015894 | Terada | Jan 2012 | A1 |
| 20120022037 | Terada | Jan 2012 | A1 |
| 20120064137 | Kawai | Mar 2012 | A1 |
| 20120114583 | Giesen et al. | May 2012 | A1 |
| 20120118316 | Uellner et al. | May 2012 | A1 |
| 20120121705 | Paus et al. | May 2012 | A1 |
| 20120180807 | Flohr | Jul 2012 | A1 |
| 20120244082 | Sulzbach et al. | Sep 2012 | A1 |
| 20120288459 | Burg et al. | Nov 2012 | A1 |
| 20120329650 | Lopez-Cervantes | Dec 2012 | A1 |
| 20130016246 | Hatanaka et al. | Jan 2013 | A1 |
| 20130034515 | Stone et al. | Feb 2013 | A1 |
| 20130102513 | Terada | Apr 2013 | A1 |
| 20130118996 | Kaplan | May 2013 | A1 |
| 20130149274 | Nguyen et al. | Jun 2013 | A1 |
| 20130152959 | Genain et al. | Jun 2013 | A1 |
| 20130156716 | Yontz | Jun 2013 | A1 |
| 20130164240 | Schrott | Jun 2013 | A1 |
| 20130172518 | Huang et al. | Jul 2013 | A1 |
| 20130216491 | Ogihara et al. | Aug 2013 | A1 |
| 20130233331 | Khenniche et al. | Sep 2013 | A1 |
| 20130233332 | Khenniche et al. | Sep 2013 | A1 |
| 20130251656 | Khenniche et al. | Sep 2013 | A1 |
| 20130266529 | Deconinck et al. | Oct 2013 | A1 |
| 20130276808 | Molenda et al. | Oct 2013 | A1 |
| 20130280199 | Albert et al. | Oct 2013 | A1 |
| 20130309190 | Dimotakis et al. | Nov 2013 | A1 |
| 20130315852 | Streuli | Nov 2013 | A1 |
| 20140120047 | Krueger | May 2014 | A1 |
| 20140158150 | Schoepgens et al. | Jun 2014 | A1 |
| 20140170105 | Chen et al. | Jun 2014 | A1 |
| 20140171354 | Miralles et al. | Jun 2014 | A1 |
| 20140186283 | Cabourg et al. | Jul 2014 | A1 |
| 20140196741 | Cabourg et al. | Jul 2014 | A1 |
| 20140246041 | Krueger | Sep 2014 | A1 |
| 20140248229 | Krueger | Sep 2014 | A1 |
| 20150004117 | Tan et al. | Jan 2015 | A1 |
| 20150004119 | Tan et al. | Jan 2015 | A1 |
| 20150034117 | Pressly et al. | Feb 2015 | A1 |
| 20150034119 | Pressly et al. | Feb 2015 | A1 |
| 20150037270 | Pressly et al. | Feb 2015 | A1 |
| 20150037271 | Pressly et al. | Feb 2015 | A1 |
| 20150053228 | Bonauer et al. | Feb 2015 | A1 |
| 20150053230 | Myatt | Feb 2015 | A1 |
| 20150090285 | Worner et al. | Apr 2015 | A1 |
| 20150157544 | Briggs et al. | Jun 2015 | A1 |
| 20150252302 | Rieth et al. | Sep 2015 | A1 |
| 20150283041 | Benn et al. | Oct 2015 | A1 |
| 20150290101 | Pressly et al. | Oct 2015 | A1 |
| 20150297496 | Kroon et al. | Oct 2015 | A1 |
| 20150305469 | Paul | Oct 2015 | A1 |
| 20150313816 | Daubresse | Nov 2015 | A1 |
| 20150328102 | Pressly et al. | Nov 2015 | A1 |
| 20160058688 | Anderheggen et al. | Mar 2016 | A1 |
| 20160081899 | Pressly et al. | Mar 2016 | A1 |
| 20160166479 | Chiou et al. | Jun 2016 | A1 |
| 20160175238 | Shin et al. | Jun 2016 | A1 |
| 20160193129 | Pressly et al. | Jul 2016 | A1 |
| 20160235649 | Streuli | Aug 2016 | A1 |
| 20160263003 | Pressly et al. | Sep 2016 | A1 |
| 20160310394 | Pressly et al. | Oct 2016 | A1 |
| 20160331664 | Anderheggen et al. | Nov 2016 | A1 |
| 20160348037 | Findlay et al. | Dec 2016 | A1 |
| 20170007518 | Everaert et al. | Jan 2017 | A1 |
| 20170112740 | Schoepgens et al. | Apr 2017 | A1 |
| 20170112743 | Schoepgens et al. | Apr 2017 | A1 |
| 20170113071 | Schoepgens et al. | Apr 2017 | A1 |
| 20170119122 | Rautenberg-Groth et al. | May 2017 | A1 |
| 20170128334 | Schoepgens et al. | May 2017 | A1 |
| 20170128342 | Schoepgens et al. | May 2017 | A1 |
| 20170143611 | Hippe et al. | May 2017 | A1 |
| 20170151143 | Scheunemann et al. | Jun 2017 | A1 |
| 20170151144 | Scheunemann et al. | Jun 2017 | A1 |
| 20170151146 | Scheunemann et al. | Jun 2017 | A1 |
| 20170151147 | Scheunemann et al. | Jun 2017 | A1 |
| 20170151156 | Scheunemann et al. | Jun 2017 | A1 |
| 20170157011 | Punyani et al. | Jun 2017 | A1 |
| 20170165161 | Manneck et al. | Jun 2017 | A1 |
| 20170172897 | Kerl et al. | Jun 2017 | A1 |
| 20170202763 | Manneck | Jul 2017 | A1 |
| 20170246094 | Dreher et al. | Aug 2017 | A1 |
| 20170252291 | Lechner et al. | Sep 2017 | A1 |
| 20170360658 | Ferrari et al. | Dec 2017 | A1 |
| 20180055751 | Gevgilili et al. | Mar 2018 | A1 |
| 20180116942 | Mahadeshwar et al. | May 2018 | A1 |
| 20180140531 | Singer et al. | May 2018 | A1 |
| 20180140532 | Singer et al. | May 2018 | A1 |
| 20180280267 | Rughani et al. | Oct 2018 | A1 |
| 20180280269 | Rughani et al. | Oct 2018 | A1 |
| 20180280270 | Rughani et al. | Oct 2018 | A1 |
| 20180280271 | Fack et al. | Oct 2018 | A1 |
| 20180338895 | Patterson et al. | Nov 2018 | A1 |
| 20180338901 | Patterson et al. | Nov 2018 | A1 |
| 20180339175 | Patterson et al. | Nov 2018 | A1 |
| 20190160000 | Herrlein et al. | May 2019 | A1 |
| 20200129405 | Mitchell et al. | Apr 2020 | A1 |
| Number | Date | Country |
|---|---|---|
| 1383377 | Dec 2002 | CN |
| 1423548 | Jun 2003 | CN |
| 1424016 | Jun 2003 | CN |
| 1454074 | Nov 2003 | CN |
| 1678281 | Oct 2005 | CN |
| 1717215 | Jan 2006 | CN |
| 1778289 | May 2006 | CN |
| 1798539 | Jul 2006 | CN |
| 101282705 | Oct 2008 | CN |
| 101495087 | Jul 2009 | CN |
| 101686920 | Mar 2010 | CN |
| 101843561 | Sep 2010 | CN |
| 101966136 | Feb 2011 | CN |
| 102056896 | May 2011 | CN |
| 102166163 | Aug 2011 | CN |
| 102231974 | Nov 2011 | CN |
| 102281864 | Dec 2011 | CN |
| 102361627 | Feb 2012 | CN |
| 102397232 | Apr 2012 | CN |
| 102451117 | May 2012 | CN |
| 103356395 | Oct 2013 | CN |
| 103998099 | Aug 2014 | CN |
| 104066419 | Sep 2014 | CN |
| 104159567 | Nov 2014 | CN |
| 104519962 | Apr 2015 | CN |
| 105267066 | Jan 2016 | CN |
| 105902403 | Aug 2016 | CN |
| 105902404 | Aug 2016 | CN |
| 106265109 | Jan 2017 | CN |
| 1220969 | Jul 1966 | DE |
| 2225541 | Dec 1973 | DE |
| 2359399 | Jun 1975 | DE |
| 3843892 | Jun 1990 | DE |
| 4133957 | Apr 1993 | DE |
| 4300320 | Jul 1994 | DE |
| 19543988 | May 1997 | DE |
| 29722990 | May 1999 | DE |
| 10051773 | Apr 2002 | DE |
| 10051774 | Apr 2002 | DE |
| 20208254 | Aug 2002 | DE |
| 10 2004 052480 | May 2006 | DE |
| 10 2007 039745 | Feb 2009 | DE |
| 20 2015 104742 | Oct 2015 | DE |
| 10 2014 213317 | Jan 2016 | DE |
| 10 2015 223828 | Sep 2016 | DE |
| 10 2015 221460 | May 2017 | DE |
| 20 2017 001430 | Jul 2017 | DE |
| 102016200688 | Jul 2017 | DE |
| 0122324 | Oct 1984 | EP |
| 0159628 | Oct 1985 | EP |
| 0286261 | Oct 1988 | EP |
| 0298684 | Jan 1989 | EP |
| 0299764 | Jan 1989 | EP |
| 0437114 | Jul 1991 | EP |
| 0512879 | Nov 1992 | EP |
| 0636358 | Feb 1995 | EP |
| 0714954 | Jun 1996 | EP |
| 0770375 | May 1997 | EP |
| 0855178 | Jul 1998 | EP |
| 0978272 | Feb 2000 | EP |
| 1118319 | Jul 2001 | EP |
| 1174112 | Jan 2002 | EP |
| 1216023 | Apr 2005 | EP |
| 1541117 | Jun 2005 | EP |
| 1570832 | Sep 2005 | EP |
| 1216022 | Apr 2006 | EP |
| 1690524 | Aug 2006 | EP |
| 1779896 | May 2007 | EP |
| 1810657 | Jul 2007 | EP |
| 2123250 | Nov 2009 | EP |
| 2165697 | Mar 2010 | EP |
| 2229933 | Sep 2010 | EP |
| 2295029 | Mar 2011 | EP |
| 2460511 | Jun 2012 | EP |
| 2471504 | Jul 2012 | EP |
| 2478892 | Jul 2012 | EP |
| 1510197 | Mar 2016 | EP |
| 1492597 | Aug 1967 | FR |
| 1583363 | Oct 1969 | FR |
| 2162025 | Jul 1973 | FR |
| 2252840 | Jun 1975 | FR |
| 2270846 | Dec 1975 | FR |
| 2336434 | Jul 1977 | FR |
| 2368508 | May 1978 | FR |
| 2413907 | Aug 1979 | FR |
| 2505348 | Nov 1982 | FR |
| 2542997 | Sep 1984 | FR |
| 2733749 | Nov 1996 | FR |
| 2789895 | Aug 2000 | FR |
| 2789896 | Aug 2000 | FR |
| 2801308 | May 2001 | FR |
| 2841129 | Dec 2003 | FR |
| 2886136 | Dec 2006 | FR |
| 2939030 | Jun 2010 | FR |
| 2944441 | Oct 2010 | FR |
| 2966352 | Apr 2012 | FR |
| 2975899 | Dec 2012 | FR |
| 2975900 | Dec 2012 | FR |
| 713675 | Aug 1954 | GB |
| 741307 | Nov 1955 | GB |
| 773559 | Apr 1957 | GB |
| 1026978 | Apr 1966 | GB |
| 1125794 | Aug 1968 | GB |
| 1153196 | May 1969 | GB |
| 1260451 | Jan 1972 | GB |
| 1546809 | May 1979 | GB |
| 1584364 | Feb 1981 | GB |
| S60-158105 | Aug 1985 | JP |
| 63-154611 | Jun 1988 | JP |
| S63-255214 | Oct 1988 | JP |
| 02-019576 | Jan 1990 | JP |
| H02-138110 | May 1990 | JP |
| 05-163124 | Jun 1993 | JP |
| H07-069847 | Mar 1995 | JP |
| 08-198732 | Aug 1996 | JP |
| H08-509478 | Oct 1996 | JP |
| 2000-229821 | Aug 2000 | JP |
| 2001-081013 | Mar 2001 | JP |
| 2002-097115 | Apr 2002 | JP |
| 2002-105493 | Apr 2002 | JP |
| 2002-121121 | Apr 2002 | JP |
| 2002-356408 | Dec 2002 | JP |
| 2002-363048 | Dec 2002 | JP |
| 2003-095876 | Apr 2003 | JP |
| 2003-516335 | May 2003 | JP |
| 2004-026976 | Jan 2004 | JP |
| 2005-060398 | Mar 2005 | JP |
| 2005-154348 | Jun 2005 | JP |
| 2006-219493 | Aug 2006 | JP |
| 2006-327994 | Dec 2006 | JP |
| 2008-169183 | Jul 2008 | JP |
| 2008-189686 | Aug 2008 | JP |
| 2009-007283 | Jan 2009 | JP |
| 2009-536619 | Oct 2009 | JP |
| 2010-155823 | Jul 2010 | JP |
| 2012-515218 | Jul 2012 | JP |
| 2013-500328 | Jan 2013 | JP |
| 2013-028564 | Feb 2013 | JP |
| 2015-086211 | May 2015 | JP |
| 2016-003185 | Jan 2016 | JP |
| 2017-095451 | Jun 2017 | JP |
| 2018-514570 | Jun 2018 | JP |
| 10-2001-0039848 | Jul 2001 | KR |
| 2003-0003970 | Jan 2003 | KR |
| 10-2004-0098688 | Nov 2004 | KR |
| 10-2006-0059564 | Jun 2006 | KR |
| 10-2012-0062511 | Jun 2012 | KR |
| 10-2016-0064420 | Jun 2016 | KR |
| 2144945 | Jan 2000 | RU |
| 2229281 | May 2004 | RU |
| 9300882 | Jan 1993 | WO |
| 9308787 | May 1993 | WO |
| 9408969 | Apr 1994 | WO |
| 9408970 | Apr 1994 | WO |
| 9501152 | Jan 1995 | WO |
| 9501772 | Jan 1995 | WO |
| 9515144 | Jun 1995 | WO |
| 9615765 | May 1996 | WO |
| 9724106 | Jul 1997 | WO |
| 9856333 | Dec 1998 | WO |
| 9911226 | Mar 1999 | WO |
| 9966793 | Dec 1999 | WO |
| 0135912 | May 2001 | WO |
| 0147486 | Jul 2001 | WO |
| 0152005 | Jul 2001 | WO |
| 0219976 | Mar 2002 | WO |
| 0232383 | Apr 2002 | WO |
| 0232386 | Apr 2002 | WO |
| 02055034 | Jul 2002 | WO |
| 2004002411 | Jan 2004 | WO |
| 2004019858 | Mar 2004 | WO |
| 2005058258 | Jun 2005 | WO |
| 2006011771 | Feb 2006 | WO |
| 2006134051 | Dec 2006 | WO |
| WO-2007003307 | Jan 2007 | WO |
| 2007038733 | Apr 2007 | WO |
| 2009024936 | Feb 2009 | WO |
| 2010015517 | Feb 2010 | WO |
| 2010049434 | May 2010 | WO |
| 2011134785 | Nov 2011 | WO |
| 2012033813 | Mar 2012 | WO |
| 2012080321 | Jun 2012 | WO |
| 2012084532 | Jun 2012 | WO |
| 2012084876 | Jun 2012 | WO |
| 2012164064 | Dec 2012 | WO |
| 2013092080 | Jun 2013 | WO |
| 2013136480 | Sep 2013 | WO |
| 2014016407 | Jan 2014 | WO |
| 2014072490 | May 2014 | WO |
| 2014118212 | Aug 2014 | WO |
| 2014125452 | Aug 2014 | WO |
| 2014144076 | Sep 2014 | WO |
| 2014167508 | Oct 2014 | WO |
| 2014207097 | Dec 2014 | WO |
| 2015017768 | Feb 2015 | WO |
| 2015026994 | Feb 2015 | WO |
| 2015033351 | Mar 2015 | WO |
| 2015058942 | Apr 2015 | WO |
| 2015069823 | May 2015 | WO |
| 2015075064 | May 2015 | WO |
| 2015118357 | Aug 2015 | WO |
| 2015175986 | Nov 2015 | WO |
| 2016005114 | Jan 2016 | WO |
| 2016005144 | Jan 2016 | WO |
| 2016058749 | Apr 2016 | WO |
| 2016069877 | May 2016 | WO |
| 2016091492 | Jun 2016 | WO |
| 2016098870 | Jun 2016 | WO |
| 2016100885 | Jun 2016 | WO |
| 2016102543 | Jun 2016 | WO |
| 2016120642 | Aug 2016 | WO |
| 2016161360 | Oct 2016 | WO |
| 2016179017 | Nov 2016 | WO |
| 2016198203 | Dec 2016 | WO |
| 2017041903 | Mar 2017 | WO |
| 2017041905 | Mar 2017 | WO |
| 2017041906 | Mar 2017 | WO |
| 2017041907 | Mar 2017 | WO |
| 2017041908 | Mar 2017 | WO |
| 2017041909 | Mar 2017 | WO |
| 2017041910 | Mar 2017 | WO |
| 2017059646 | Apr 2017 | WO |
| 2017085117 | May 2017 | WO |
| 2017091794 | Jun 2017 | WO |
| 2017091796 | Jun 2017 | WO |
| 2017091797 | Jun 2017 | WO |
| 2017091800 | Jun 2017 | WO |
| 2017102855 | Jun 2017 | WO |
| 2017102936 | Jun 2017 | WO |
| 2017116465 | Jul 2017 | WO |
| 2017196299 | Nov 2017 | WO |
| WO-2017207198 | Dec 2017 | WO |
| 2018081399 | May 2018 | WO |
| WO-2018085478 | May 2018 | WO |
| Entry |
|---|
| International Search Report and Written Opinion dated Feb. 25, 2019 for corresponding PCT Application No. PCT/US2018/067814. |
| Mintel: “Conditioner,” Unilever, XP055576893, Database Accession No. 3014885, Mar. 2, 2015. |
| “Olaplex Alleges Patent Infringement by L'OREAL re Hairbond-Building Prior to Colouring,” Focus on Pigments, vol. 2017, No. 3, Mar. 31, 2017, p. 7. |
| Final Office Action for copending U.S. Appl. No. 15/339,035, dated May 2, 2019. |
| International Preliminary Report on Patentability for counterpart Application No. PCT/US2017/058495, dated May 9, 2019. |
| Notice of Allowance for copending Application No. 15/778,803, dated Jun. 3, 2019. |
| Extended European Search Report for counterpart Application No. 16869327.3-1114, dated Jun. 4, 2019. |
| Mintel: “Detox 7 Day Cure Purifying Serum,” XP055593471, Jeanne Gatineau, Feb. 11, 2013. |
| Extended European Search Report for counterpart Application No. 1689330.7-1114, dated Jul. 5, 2019. |
| Extended European Search Report for counterpart Application No. 16869326.5-1114, dated Jun. 26, 2019. |
| Translation of Mexican Office Action for counterpart Application No. MX/a/2018/005829, dated Jun. 13, 2019. |
| Non-Final Office Action for copending U.S. Appl. No. 15/339,035, dated Aug. 20, 2019. |
| Mexican Office Action for counterpart Application No. MX/a/2017/013983, dated Jul. 2, 2019. |
| Notice of Allowance for copending U.S. Appl. No. 16/042,478, dated Sep. 25, 2019. |
| Non-Final Office Action for copending U.S. Appl. No. 15/778,807, dated Sep. 30, 2019. |
| Brazilian Office Action for counterpart Application No. BR112017023380-0, dated Oct. 10, 2019. |
| Brazilian Office Action for counterpart Application No. BR112018010381-0, dated Nov. 25, 2019. |
| Brazilian Office Action for counterpart Application No. BR112018010357-8, dated Nov. 25, 2019. |
| Mexican Office Action for counterpart Application No. MX/a/2018/005829, dated Oct. 5, 2019. |
| Brazilian Office Action for counterpart Application No. BR112018010344, dated Nov. 25, 2019. |
| Mexican Office Action for counterpart Application No. MX/a/2017/013983, dated Dec. 16, 2019. |
| Japanese Office Action for counterpart Application No. 2018-526844, dated Dec. 23, 2019. |
| Japanese Office Action for counterpart Application No. 2018-526845, dated Dec. 23, 2019. |
| Japanese Office Action for counterpart Application No. 2018-546409, dated Dec. 23, 2019. |
| Brazilian Written Opinion for counterpart Application No. BR112018010341, dated Nov. 25, 2019. |
| Non-Final Office Action for counterpart Japanese Application No. 2018-546408, dated Jan. 6, 2020. |
| Mintel: “Tonic,” Dr. Kurt Wolff, Dr. Wolff Plantur 39, ID# 3133037, Apr. 2015. |
| Mintel: “Conditioner,” LG Household & Health Care, Beyond Professional, ID# 3240637, Jun. 2015. |
| Russian Office Action for counterpart Application No. 2018114758/04, dated Dec. 13, 2019. |
| Translated Notification of Reasons for Refusal for counterpart KR Application No. 10-2018-7017668, dated Jan. 21, 2020. |
| Translated Office Action for counterpart RU Application No. 2017134681/04(0060925), dated Dec. 30, 2019. |
| Non-Final Office Action for copending U.S. Appl. No. 15/778,805, dated Feb. 12, 2020. |
| Final Office Action for copending Application No. 15/778,807, dated Mar. 13, 2020. |
| Final Office Action for copending U.S. Appl. No. 15/339,035, dated Apr. 10, 2020. |
| Non-Final Office Action for copending U.S. Appl. No. 16/273,787, dated Apr. 9, 2020. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2017/059827, dated Jun. 28, 2018. |
| “LAMESOI-1® PO 65 Datasheet,” Retrieved from the internet on Jun. 7, 2018, http://e-applications.basf-ag.de/data/basf-pcan/pds2/pds2-web.nsf. |
| Non-Final Office Action for copending U.S. Appl. No. 15/356,967, dated May 3, 2017. |
| Final Office Action for copending U.S. Appl. No. 15/356,967, dated Dec. 4, 2017. |
| Non-Final Office Action for copending U.S. Appl. No. 15/356,967, dated Aug. 24, 2018. |
| Final Office Action for copending U.S. Appl. No. 15/356,967, dated Apr. 11, 2019. |
| Non-Final Office Action for copending U.S. Appl. No. 15/356,967, dated Feb. 21, 2020. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2017/059817, dated Feb. 6, 2018. |
| Non-Final Office Action for copending U.S. Appl. No. 15/357,056, dated Apr. 16, 2020. |
| Non-Final Office Action for copending U.S. Appl. No. 15/942,042, dated Jan. 24, 2020. |
| ALS “Cocamidopropyl betaine,” printed 2020; https://www.caslab.com/Cocamidopropyl_betaine_CAS_61789-40-0. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2018/025466, dated Jul. 9, 2018. |
| International Preliminary Report on Patentability for counterpart Application No. PCT/US2018/025466, dated Oct. 1, 2019. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2018/025448, dated Jul. 9, 2018. |
| International Preliminary Report on Patentability for counterpart Application No. PCT/US2018/025448, dated Oct. 1, 2019. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2018/025431, dated Jun. 20, 2018. |
| International Preliminary Report on Patentability for counterpart Application No. PCT/US2018/025431, dated Oct. 1, 2019. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2018/025418, dated Jun. 21, 2018. |
| International Preliminary Report on Patentability for counterpart Application No. PCT/US2018/025418, dated Oct. 1, 2019. |
| Notice of Allowance for copending U.S. Appl. No. 15/604,152, dated Oct. 2, 2019 (now U.S. Pat. No. 10,561,599). |
| Non-Final Office Action for copending U.S. Appl. No. 15/604,152, dated Jun. 13, 2019. |
| Olaplex with relaxers, OLAPLEX™, pp. 1-2, Apr. 11, 2017, https://olaplex.es/olaplex-with-relaxers/. |
| Relaxers, resource Library, Olaplex Education, pp. 1-2, Apr. 11, 2017, https://help.olaplex.com/detail/relaxers. |
| Noticeof Allowability for copending U.S. Appl. No. 15/604,152, dated Dec. 10, 2019. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2018/034366, dated Jul. 25, 2018. |
| Anonymous: “Curly Hair Conditioner,” Mintel, GNPD, XP002782449, 2015, pp. 1-2. |
| Corrected Noticeof Allowability for copending U.S. Appl. No. 15/604,189, dated Dec. 11, 2019. |
| Notice of Allowance for copending U.S. Appl. No. 15/604,189, dated Oct. 22, 2019 (now U.S. Pat. No. 10,576,307). |
| Non-Final Office Action for copending U.S. Appl. No. 15/604,189, dated Apr. 8, 2019. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2018/034371, dated Nov. 16, 2018. |
| Mintel: “Hydrating Hair Colour,” Garnier, Jan. 2017, pp. 1-6. |
| Mintel, “Masque Force Architecte Reconstructing Masque,” L'Oreal, Feb. 2012, pp. 1-6. |
| Final Office Action for copending U.S. Appl. No. 15/603,889, dated Jul. 12, 2019. |
| Non-Final Office Action for copending U.S. Appl. No. 15/603,889, dated Jan. 2, 2019. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2018/034378, dated Jul. 24, 2018. |
| Final Office Action for copending U.S. Appl. No. 16/234,883, dated Mar. 11, 2020. |
| Non-Final Office Action for copending U.S. Appl. No. 16/234,883, dated Sep. 16, 2019. |
| Final Office Action for copending U.S. Appl. No. 16/176,350, dated Apr. 8, 2020. |
| Non-Final Office Action for copending U.S. Appl. No. 16/176,350, dated Nov. 14, 2019. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2019/059002, dated Feb. 4, 2020. |
| Translated Korean Notification of Reason for Refusal for counterpart Application No. KR10-2017-7034789, dated May 19, 2020. |
| Final Office Action for copending U.S. Appl. No. 15/942,042, dated Jun. 1, 2020. |
| Translated Japanese Notice of Reasons for Refusal by Application No. 2017-557074, dated Jun. 1, 2020. |
| Non-Final Office Action for copending U.S. Appl. No. 15/942,085, dated Jun. 19, 2020. |
| Non-Final Office Action for copending U.S. Appl. No. 15/941,916, dated Jun. 24, 2020. |
| Shiseido Super Mild Hair Care—Shampoo and Conditioner Refill Set. https://web.archive.org/web/20160326190615/http://www.truenu.com/TR/Shiseido-Super-Mild-Hair-Care-Shampoo-Conditioner-Refill-Set-Two-400ml-Refill-Pouches-Details.html. Published Mar. 26, 2016. |
| Non-Final Office Action for copending U.S. Appl. No. 15/941,965, dated Jul. 15, 2020. |
| Third Party Observation for counterpart Application No. EP 20160869330, dated Jun. 26, 2020. |
| Third Party Observation for counterpart Application No. EP 20160869326, dated Jul. 2, 2020. |
| Third Party Observation for counterpart Application No. EP 20160869327, dated Jul. 2, 2020. |
| Translation of Japanese Office Action for counterpart Application No. 2018-526844, dated Aug. 3, 2020. |
| Copending U.S. Appl. No. 15/484,625, filed Apr. 11, 2017 (WO2016179017A1). |
| Copending U.S. Appl. No. 15/484,663, filed Apr. 11, 2017 (WO2017091794A1). |
| Copending U.S. Appl. No. 15/339,035, filed Oct. 31, 2016 (WO2018081399A1). |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2016/030172, dated Sep. 19, 2016. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2016/063724, dated Feb. 2, 2017. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2016/063727, dated Feb. 3, 2017. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2016/063732, dated Feb. 3, 2017. |
| International Search Report and Written Opinion for counterpart Application No. PCT/US2016/063728, dated Feb. 1, 2017. |
| Mintel: “Abundant Volume Conditioner,” Alterna Professional Haircare, Database Record No. 2177147, Sep. 2013. |
| Mintel: “Hair Colourant,” Catzy Hair Colourant, Database Record ID 743114, Jul. 2007, 4 pages. |
| Mintel: “Combing Cream,” Devintex Cosmeticos, Database Record No. 1595490, Jul. 2011. |
| Mintel: “Combing Cream,” Devintex Cosmeticos, Database Record No. 1595658, Jul. 2011. |
| Mintel: “Conditioner,” Devintex Cosmeticos, Database Record No. 1595545, Jul. 2011. |
| Mintel: “Conditioner,” Laperle Haircare, Database Record No. 3645337, Feb. 2016. |
| Mintel: “Conditioner,” Laperle Haircare, Database Record No. 3790215, Feb. 2016. |
| Mintel: “Conditioner,” Liqwd, Database Record No. 1172691, Sep. 2009. |
| Mintel: “Conditioner,” TIGI, Database Record No. 1442418, Nov. 2010. |
| Mintel: “Conditioner,” TIGI International, Database Record No. 1445427, Nov. 2010. |
| Mintel: “Conditioner,” TGI International, Database Record No. 3280151, Jul. 2015. |
| Mintel, “Masque for Beautiful Color,” Oribe Hair Care, Database Record No. 1522953, Mar. 2011. |
| Mintel: “Moisturizing Conditioner,” Frederic Fekkai, Database Record No. 1507159, Mar. 2011. |
| Mintel: “Post-Service Perfector,” Redken, Database Record No. 4326453, Nov. 2016. |
| Mintel: “Step 3-Conditioner,” L'OREAL, Database Record No. 4353779, Oct. 2016. |
| Mintel: “Step 3-Conditioner,” L'OREAL, Database Record No. 4609117, Feb. 2017. |
| International Preliminary Report on Patentability for counterpart Application No. PCT/US2016/30172, dated Jun. 19, 2017. |
| Petition for Post-Grant Review of U.S. Pat. No. 9,498,419, filed Jan. 31, 2017, with Exhibits. |
| Non-Final Office Action for copending U.S. Appl. No. 15/484,625, mailed Jun. 21, 2017. |
| Final Office Action for copending U.S. Appl. No. 15/484,625, dated Nov. 14, 2017. |
| Non-Final Office Action for copending U.S. Appl. No. 15/484,663, dated Jun. 21, 2017. |
| Final Office Action for copending U.S. Appl. No. 15/484,663, dated Nov. 28, 2017. |
| Non-Final Office Action for copending U.S. Appl. No. 15/339,035, dated Jan. 10, 2018. |
| International Search Report for counterpart Application No. PCT/US2017/058495, dated Jan. 5, 2018. |
| Third Party Submission for U.S. Appl. No. 15/484,663, filed Feb. 28, 2018 with attachments. |
| Pressly, Eric et al., U.S. Appl. No. 61/994,709, filed May 16, 2014 and became publicly available on Nov. 19, 2015. |
| Estetica: the hairstyling professional magazine, (http://estetica.it/int/a/schwarzkopf-professional-launches-fibreplex), “Schwarzkopf Professional Launches Fibreplex®,” published Sep. 23, 2015 reporting that Fibreplex was launched during Sep. 2015. |
| Fibreplex® No. 1 Product Label. |
| Fibreplex® No. 1 Material Safety Data Sheet. |
| International Preliminary Report on Patentability for counterpart Application No. PCT/US2016/063727, dated Jun. 7, 2018. |
| International Preliminary Report on Patentability for counterpart Application No. PCT/US2016/063732, dated Jun. 7, 2018. |
| International Preliminary Report on Patentability for counterpart Application No. PCT/US2016/063728, dated Jun. 7, 2018. |
| Non-Final Office Action for copending U.S. Appl. No. 15/484,625, dated Jun. 20, 2018. |
| International Preliminary Report on Patentability for counterpart Application No. PCT/US2016/063724, dated Jun. 7, 2018. |
| Non-Final Office Action for copending U.S. Appl. No. 15/339,035, dated Oct. 5, 2018. |
| Notice of Allowance for copending U.S. Appl. No. 15/484,625, dated Oct. 31, 2018. |
| Bayraktar, V.N., “Organic Acids Concentration in Wine Stocks After Saccharomyces cerevisiae Fermentation,” Biotechnologia Acta, vol. 6, No. 2, Jan. 1, 2013, pp. 97-106. |
| Supplementary European Search Report for counterpart Application No. EP16789846, dated Oct. 30, 2018. |
| Communication Pursuant to Rules 70(32) and 70A(2) EPC for counterpart Application No. EP16789846, dated Jan. 23, 2019. |
| Written Opinion for counterpart Application No. EP16789846, dated Jan. 23, 2019. |
| Supplementary Extended Search Report and Written Opinion for counterpart European U.S. Appl. No. 16/869,324, dated Apr. 25, 2019. |
| Mintel: “Conditioner,” Unilever, XP-55576888, Database accession No. 1419415, Oct. 21, 2010. |
| Chinese Office Action for counterpart Application No. 201880021603.6, dated Mar. 2, 2021. |
| Translation of Chinese Office Action for counterpart Application No. 201680039105.5, dated Feb. 4, 2021. |
| European Office Action for counterpart Application No. 16869330.7-1112, dated Feb. 4, 2021. |
| European Office Action for counterpart Application No. 16869324.0-1112, dated Feb. 18, 2021. |
| Translation of Chinese Office Action for counterpart Application No. 201680079800.4, dated Feb. 24, 2021. |
| Supplemental Search Report for Chinese counterpart Application No. 201680079800.4, dated Feb. 18, 2021. |
| Non-Final Office Action for copending U.S. Appl. No. 16/455,139, dated Jan. 26, 2021. |
| Translation of Third Party Observation for Application No. 2018-546408, dated Sep. 11, 2020. |
| European Office Action for counterpart Application No. 16869327.3-1112, dated Dec. 18, 2020. |
| Translation of Russian Office Action for counterpart Application No. 2018114758/04, dated Dec. 21, 2020. |
| Final Office Action for copending U.S. Appl. No. 15/941,916, dated Mar. 10, 2021. |
| Translation of Chinese Office Action for counterpart Application No. 201680079110.9, dated Aug. 11, 2020. |
| Ruiming, Li, “Hairdressing Technology,” China Railway Publishing House, Jun. 30, 2015, pp. 112-113. |
| Translation of Mexican Office Action for counterpart Application No. MX/a/2018/005829 dated Jul. 13, 2020. |
| Mascolo Group, label.m Anti-Frizz Mist, MINTEL GNPD, record ID5618119, published Apr. 2018, p. 1-5. |
| Federici Brands, Color WOW Dream Coat Supernatural Spray, MINTEL GNPD, record ID5637153, published Apr. 2018, p. 1-2. |
| Gamier, Gamier Fructis Sleek & Shine Moroccan Sleek Oil Treatment, MINTEL GNPD, record ID1876023, published Sep. 2012, p. 1-2. |
| Ouai, Leave-In Conditioner, MINTEL GNPD, record ID5781323, published Jun. 2018, p. 1-2. |
| Redken, Redken Pillow Proof Express Treatment Primer, MINTEL GNPD, record ID5117339, published Sep. 2017, p. 1-4. |
| Redken, Redken Pillow Proof Express Primer Time-Saving Blowdry Primer with Heat Protection, MINTEL GNPD, record ID6117357, published Nov. 2018, p. 1-2. |
| Redken, Redken Pillow Proof Time-Saving Blowdry Primer with Heat Protection, MINTEL GNPD, record ID4537755, published Jan. 2017, p. 1-3. |
| Copending U.S. Appl. No. 16/455,139, “Hair Treatment Compositions and Methods for Treating Hair,” filed Jun. 27, 2019. |
| Translation of Russian Office Action for counterpart Application No. 2017134681-04, dated Aug. 17, 2020. |
| Translation of Chinese Office Action for counterpart Application No. 201680079800.4, dated Aug. 24, 2020. |
| Search Report for Chinese Application No. 201680079800.4, dated Aug. 24, 2020. |
| Translation of Chinese Office Action for counterpart Application No. 201680079773.0, dated Aug. 21, 2020. |
| Search report for counterpart Chinese Application No. 201680079773.0, dated Aug. 21, 2020. |
| Translation of Japanese Office Action for counterpart Application No. 2018-546409, dated Sep. 7, 2020. |
| Translation of Chinese Office Action for counterpart Application No. 201680079774.5, dated Sep. 1, 2020. |
| Fridman, R.A., “Technology of Cosmetics,” publ. of “Food Industry,” 1964, pp. 3-6, 297-308, 411-428 and 44 1-466 (translation). |
| Zefirova, N.S., “Big Russian Encyclopedia,” Chemical Encylopedia, 1995, vol. 4, pp. 183-185 (translation). |
| Third Party Submission for U.S. Appl. No. 16/712,326 with attachments, filed Sep. 8, 2020. |
| Mexican Office Action for counterpart Application No. MX/a/2017/013983, dated Sep. 15, 2020. |
| Non-Final Office Action for copending U.S. Appl. No. 16/176,350, dated Sep. 30, 2020. |
| Non-Final Office Action for copending U.S. Appl. No. 15/778,807, dated Oct. 9, 2020. |
| Japanese Notice of Reasons for Refusal for counterpart Application No. 2019-553190, dated Oct. 27, 2020. |
| Translation of Korean Notice of Last Preliminary Rejection for counterpart Application No. 10-2018-7017668, dated Oct. 21, 2020. |
| Non-Final Office Action for copending U.S. Appl. No. 15/942,042, dated Nov. 12, 2020. |
| Final Office Action for copending U.S. Appl. No. 15/356,967, dated Nov. 17, 2020. |
| Final Office Action for copending U.S. Appl. No. 15/357,056, dated Nov. 19, 2020. |
| Japanese Office Action for counterpart Application No. 2018-546408, dated Dec. 7, 2020. |
| Japanese Notice of Reasons for Rejection for counterpart Application No. 2019-553559, dated Dec. 1, 2020. |
| Japanese Notice of Reasons for Rejection for counterpart Application No. 2019-564945, dated Dec. 1, 2020. |
| Final Office Action for copending U.S. Appl. No. 15/941,965, dated Apr. 5, 2021. |
| Non-Final Office Action for copending U.S. Appl. No. 16/234,883, dated Sep. 17, 2021. |
| Final Office Action for copending U.S. Appl. No. 15/942,085, dated Sep. 21, 2021. |
| Final Office Action for copending U.S. Appl. No. 15/603,889, dated Jan. 6, 2022. |
| Final Office Action for copending U.S. Appl. No. 15/942,042, dated May 12, 2021. |
| Non-Final Office Action for copending U.S. Appl. No. 15/942,085, dated Jun. 8, 2021. |
| Tetrasodium Etidronate, https://uk.lush.com/ingredients/tetrasodium-etidronate. Published Mar. 28, 2020. |
| Shoup, F.K., et al., “Amino Acid Composition of Wheat Varieties and Flours Varying Widely in Bread-Making Potentialities,” Journal of Food Science, vol. 31, Issue 1, published Jan. 1966, pp. 94-101. |
| “Oxy Cream,” Makki Cosmetics, https://www.makkicosmetics.com/makki/showProductjsp?productID=Oxy25030&brandID=Makki, published Jun. 30, 2016. |
| Non-Final Office Action for copending U.S. Appl. No. 15/339,035, dated Jun. 25, 2021. |
| Non-Final Office Action for copending U.S. Appl. No. 15/603,889, dated Jun. 25, 2021. |
| Partial Translation of Office Action for copending MX Application No. MX/a/2017/013983, dated Apr. 4, 2021. |
| Translation of Chinese Office Action for counterpart Application No. 201680079773, dated Apr. 14, 2021. |
| Translation of Japanese Office Action for counterpart Application No. 2017-557074, dated May 31, 2021. |
| Translation of Japanese Notice of Reasons for Refusal for counterpart Application No. 2019-553190, dated Jun. 12, 2021. |
| Final Office Action for copending Application No. 15/778,807, dated Jul. 21, 2021. |
| Non-Final Office Action for copending U.S. Appl. No. 15/356,967, dated Jul. 22, 2021. |
| Copending U.S. Appl. No. 17/228,040, Titled: “Compositions for Altering the Color of Hair,” Inventors: Kimberly Dreher et al., filed Apr. 12, 2021. |
| Copending U.S. Appl. No. 17/403,327, Titled: Hair Treatment Compositions, Methods, and Kits for Treating Hair, Inventors: Barbara Mitchell et al., filed Aug. 16, 2021. |
| Final Office Action for copending U.S. Appl. No. 16/455,139, dated Aug. 11, 2021. |
| Chinese Office Action for counterpart Application No. 201880021603.6, dated Dec. 8, 2021. |
| Chinese Office Action for counterpart Application No. 201880034065.4, dated Dec. 22, 2021. |
| Translation of Chinese Office Action for counterpart Application No. 201680039105.5, dated Jan. 14, 2022. |
| Translation of Chinese Office Action for counterpart Application No. 201880034056.6, dated Dec. 28, 2021. |
| Non-Final Office Action for copending U.S. Appl. No. 15/941,965, dated Aug. 22, 2022. |
| Non-Final Office Action for copending U.S. Appl. No. 15/942,085, dated Aug. 23, 2022. |
| Third Party Submission for copending U.S. Appl. No. 17/403,327, filed Jun. 27, 2022. |
| Non-Final Office Action for copending U.S. Appl. No. 15/942,042, dated May 23, 2022. |
| Translation of Second Chinese Office Action for counterpart Application No. 201880034056.5, dated May 30, 2022. |
| Translation of First Chinese Office Action for counterpart Application No. 201880084390.1, dated Jun. 30, 2022. |
| European Office Action for counterpart Application No. 16789846.9-1 109, dated Jul. 6, 2022, translation. |
| Korean Notice of Final Rejection for counterpart KR Application No. 10-2021-7019867, dated Jul. 22, 2022, translation. |
| Translation of Japanese Notice of Reasons for Rejection of Correction for counterpart Opposition No. 2022-700161, dated Aug. 18, 2022. |
| Translation of Korean Office Action for counterpart Application No. 10-2021-7020401, dated Aug. 25, 2022. |
| Non-Final Office Action for copending U.S. Appl. No. 15/339,035, dated Oct. 27, 2022. |
| Translation of Chinese Office Action for counterpart Application No. 2019800675489, dated Oct. 12, 2022. |
| Non-Final Office Action for copending U.S. Appl. No. 15/356,967, dated Dec. 30, 2022. |
| Third Party Submission for copending U.S. Appl. No. 17/694,821, dated Dec. 19, 2022. |
| Translation of Notice of Reasons for Rejection of counterpart Japanese Application No. 2022-020688, dated Jan. 10, 2023. |
| Translation of Chinese Decision on Rejection for counterpart CN Application No. 201880034056.5, dated Jan. 9, 2023. |
| Non-Final Office Action for copending U.S. Appl. No. 17/356,131, dated Jan. 19, 2023. |
| Number | Date | Country | |
|---|---|---|---|
| 20190201309 A1 | Jul 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62611865 | Dec 2017 | US |
